UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, DC 20549
FORM 10-Q
(Mark One)
| |
☒ | QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 |
For the quarterly period ended September 30, 2024
OR
| |
☐ | TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 |
For the transition period from to
Commission File Number: 001-39394
Montrose Environmental Group, Inc.
(Exact Name of Registrant as Specified in its Charter)
| |
Delaware | 46-4195044 |
( State or other jurisdiction of incorporation or organization) | (I.R.S. Employer Identification No.) |
5120 Northshore Drive, North Little Rock, Arkansas | 72118 |
(Address of principal executive offices) | (Zip Code) |
Registrant’s telephone number, including area code: (501) 900-6400
Securities registered pursuant to Section 12(b) of the Act:
| | | | |
Title of each class | | Trading Symbol(s) | | Name of each exchange on which registered |
Common Stock, par value $0.000004 per share | | MEG | | The New York Stock Exchange |
Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days. Yes ☒ No ☐
Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T (§232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit such files). Yes ☒ No ☐
Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, smaller reporting company, or an emerging growth company. See the definitions of “large accelerated filer,” “accelerated filer,” “smaller reporting company,” and “emerging growth company” in Rule 12b-2 of the Exchange Act.
| | | | | | |
Large accelerated filer |
| ☒ |
| Accelerated filer |
| ☐ |
| | | |
Non-accelerated filer |
| ☐ |
| Smaller reporting company |
| ☐ |
| | | | | | |
Emerging growth company | | ☐ | | | | |
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐
Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act). Yes ☐ No ☒
As of November 1, 2024, the registrant had 34,300,748 shares of common stock, $0.000004 par value per share, outstanding.
Table of Contents
PART I—FINANCIAL INFORMATION
Item 1. Financial Statements.
MONTROSE ENVIRONMENTAL GROUP, INC.
UNAUDITED CONDENSED CONSOLIDATED STATEMENTS OF FINANCIAL POSITION
(In thousands, except share data)
| | | | | | | | |
| | September 30, | | | December 31, | |
| | 2024 | | | 2023 | |
Assets | | | | | | |
Current assets | | | | | | |
Cash, cash equivalents and restricted cash | | $ | 13,045 | | | $ | 23,240 | |
Accounts receivable, net | | | 152,849 | | | | 112,360 | |
Contract assets | | | 65,553 | | | | 51,629 | |
Prepaid and other current assets | | | 15,489 | | | | 13,695 | |
Total current assets | | | 246,936 | | | | 200,924 | |
Non-current assets | | | | | | |
Property and equipment, net | | | 66,096 | | | | 56,825 | |
Operating lease right-of-use asset, net | | | 40,923 | | | | 32,260 | |
Finance lease right-of-use asset, net | | | 17,242 | | | | 13,248 | |
Goodwill | | | 482,607 | | | | 364,449 | |
Other intangible assets, net | | | 144,652 | | | | 140,813 | |
Other assets | | | 8,437 | | | | 8,267 | |
Total assets | | $ | 1,006,893 | | | $ | 816,786 | |
Liabilities, Convertible and Redeemable Series A-2 Preferred Stock and Stockholders’ Equity | | | | | | |
Current liabilities | | | | | | |
Accounts payable and other accrued liabilities | | $ | 57,579 | | | $ | 59,920 | |
Accrued payroll and benefits | | | 31,556 | | | | 34,660 | |
Business acquisitions contingent consideration, current | | | 6,423 | | | | 3,592 | |
Current portion of operating lease liabilities | | | 11,696 | | | | 9,963 | |
Current portion of finance lease liabilities | | | 4,232 | | | | 3,956 | |
Current portion of long-term debt | | | 16,753 | | | | 14,196 | |
Total current liabilities | | | 128,239 | | | | 126,287 | |
Non-current liabilities | | | | | | |
Business acquisitions contingent consideration, long-term | | | 27,924 | | | | 2,448 | |
Other non-current liabilities | | | 6,355 | | | | 6,569 | |
Deferred tax liabilities, net | | | 8,274 | | | | 6,064 | |
Conversion option related to Series A-2 Preferred Stock | | | 20,054 | | | | 19,017 | |
Operating lease liability, net of current portion | | | 31,543 | | | | 25,048 | |
Finance lease liability, net of current portion | | | 9,378 | | | | 8,185 | |
Long-term debt, net of deferred financing fees | | | 233,007 | | | | 148,988 | |
Total liabilities | | $ | 464,774 | | | $ | 342,606 | |
Commitments and contingencies | | | | | | |
Convertible and redeemable Series A-2 Preferred Stock $0.0001 par value | | | | | | |
Authorized, issued and outstanding shares: 11,667 and 17,500 at September 30, 2024 and December 31, 2023, respectively; aggregate liquidation preference of $122.2 million and $182.2 million at September 30, 2024 and December 31, 2023, respectively | | | 92,928 | | | | 152,928 | |
Stockholders’ equity: | | | | | | |
Common stock, $0.000004 par value; authorized shares: 190,000,000 at September 30, 2024 and December 31, 2023; issued and outstanding shares: 34,296,493 and 30,190,231 at September 30, 2024 and December 31, 2023, respectively | | | — | | | | — | |
Additional paid-in-capital | | | 693,931 | | | | 531,831 | |
Accumulated deficit | | | (244,447 | ) | | | (210,356 | ) |
Accumulated other comprehensive (loss) income | | | (293 | ) | | | (223 | ) |
Total stockholders’ equity | | | 449,191 | | | | 321,252 | |
Total liabilities, convertible and redeemable Series A-2 Preferred Stock and Stockholders’ Equity | | $ | 1,006,893 | | | $ | 816,786 | |
The accompanying notes are an integral part of these unaudited condensed consolidated financial statements.
MONTROSE ENVIRONMENTAL GROUP, INC.
UNAUDITED CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS AND
COMPREHENSIVE LOSS
(In thousands, except per share data)
| | | | | | | | | | | | | | | | |
| | Three Months Ended September 30, | | | Nine Months Ended September 30, | |
| | 2024 | | | 2023 | | | 2024 | | | 2023 | |
Revenues | | $ | 178,687 | | | $ | 167,937 | | | $ | 507,337 | | | $ | 458,466 | |
Cost of revenues (exclusive of depreciation and amortization shown below) | | | 105,596 | | | | 102,155 | | | | 306,239 | | | | 281,984 | |
Selling, general and administrative expense | | | 60,869 | | | | 56,901 | | | | 177,182 | | | | 161,761 | |
Fair value changes in business acquisition contingencies | | | 143 | | | | 459 | | | | 385 | | | | 414 | |
Depreciation and amortization | | | 13,240 | | | | 11,863 | | | | 37,408 | | | | 33,816 | |
Loss from operations | | | (1,161 | ) | | | (3,441 | ) | | | (13,877 | ) | | | (19,509 | ) |
Other income (expense), net | | | (3,898 | ) | | | (671 | ) | | | (4,314 | ) | | | (1,560 | ) |
Interest expense, net | | | (4,137 | ) | | | (2,089 | ) | | | (11,420 | ) | | | (5,507 | ) |
Total other income (expense), net | | | (8,035 | ) | | | (2,760 | ) | | | (15,734 | ) | | | (7,067 | ) |
Loss before expense from income taxes | | | (9,196 | ) | | | (6,201 | ) | | | (29,611 | ) | | | (26,576 | ) |
Income tax expense | | | 1,368 | | | | 1,324 | | | | 4,480 | | | | 2,842 | |
Net loss | | $ | (10,564 | ) | | $ | (7,525 | ) | | $ | (34,091 | ) | | $ | (29,418 | ) |
| | | | | | | | | | | | |
Equity adjustment from foreign currency translation | | | (70 | ) | | | (198 | ) | | | (70 | ) | | | (304 | ) |
Comprehensive loss | | | (10,634 | ) | | | (7,723 | ) | | | (34,161 | ) | | | (29,722 | ) |
Convertible and redeemable Series A-2 Preferred Stock dividend | | | (2,750 | ) | | | (4,100 | ) | | | (8,314 | ) | | | (12,300 | ) |
Net loss attributable to common stockholders | | | (13,314 | ) | | | (11,625 | ) | | | (42,405 | ) | | | (41,718 | ) |
Weighted average common shares outstanding— basic and diluted | | | 34,242 | | | | 30,143 | | | | 32,647 | | | | 30,016 | |
Net loss per share attributable to common stockholders— basic and diluted | | $ | (0.39 | ) | | $ | (0.39 | ) | | $ | (1.30 | ) | | $ | (1.39 | ) |
The accompanying notes are an integral part of these unaudited condensed consolidated financial statements.
MONTROSE ENVIRONMENTAL GROUP, INC.
UNAUDITED CONDENSED CONSOLIDATED STATEMENTS OF CONVERTIBLE AND REDEEMABLE SERIES A-2 PREFERRED STOCK AND STOCKHOLDERS’ EQUITY
(In thousands, except share data)
| | | | | | | | | | | | | | | | | | | | | | | | | |
| | | | | | | | | | | | | | Accumulated | | | |
| | Convertible and Redeemable | | | | | | Additional | | | | Other | | Total | |
| | Series A-2 Preferred Stock | | Common Stock | | Paid-In | | Accumulated | | Comprehensive | | Stockholders' | |
| | Shares | | Amount | | Shares | | Amount | | Capital | | Deficit | | Income (Loss) | | Equity | |
Balance at December 31, 2022 | | | 17,500 | | $ | 152,928 | | | 29,746,793 | | $ | — | | $ | 492,676 | | $ | (179,497 | ) | $ | 8 | | $ | 313,187 | |
Net loss | | | — | | | — | | | — | | | — | | | — | | | (14,719 | ) | | — | | | (14,719 | ) |
Stock-based compensation | | | — | | | — | | | — | | | — | | | 13,035 | | | — | | | — | | | 13,035 | |
Dividend payment to the Series A-2 preferred stockholders | | | — | | | — | | | — | | | — | | | (4,100 | ) | | — | | | — | | | (4,100 | ) |
Common stock issuances pursuant to exercises and vesting of equity awards | | | — | | | — | | | 214,571 | | | — | | | 2,690 | | | — | | | — | | | 2,690 | |
Accumulated other comprehensive income | | | — | | | — | | | — | | | — | | | — | | | — | | | 12 | | | 12 | |
Balance at March 31, 2023 | | | 17,500 | | $ | 152,928 | | | 29,961,364 | | $ | — | | $ | 504,301 | | $ | (194,216 | ) | $ | 20 | | $ | 310,105 | |
Net loss | | | — | | | — | | | — | | | — | | | — | | | (7,174 | ) | | — | | | (7,174 | ) |
Stock-based compensation | | | — | | | — | | | — | | | — | | | 11,090 | | | — | | | — | | | 11,090 | |
Dividend payment to the Series A-2 preferred shareholders | | | — | | | — | | | — | | | — | | | (4,100 | ) | | — | | | — | | | (4,100 | ) |
Common stock issuances pursuant to exercises and vesting of equity awards | | | — | | | — | | | 43,538 | | | — | | | 605 | | | — | | | — | | | 605 | |
Acquisitions consideration paid in common stock | | | — | | | — | | | 86,577 | | | — | | | 2,598 | | | — | | | — | | | 2,598 | |
Accumulated other comprehensive loss | | | — | | | — | | | — | | | — | | | — | | | — | | | (118 | ) | | (118 | ) |
Balance at June 30, 2023 | | | 17,500 | | $ | 152,928 | | | 30,091,479 | | $ | — | | $ | 514,494 | | $ | (201,390 | ) | $ | (98 | ) | $ | 313,006 | |
Net loss | | | — | | | — | | | — | | | — | | | — | | | (7,525 | ) | | — | | | (7,525 | ) |
Stock-based compensation | | | — | | | — | | | — | | | — | | | 11,484 | | | — | | | — | | | 11,484 | |
Dividend payment to the Series A-2 preferred shareholders | | | — | | | — | | | — | | | — | | | (4,100 | ) | | — | | | — | | | (4,100 | ) |
Common stock issuances pursuant to exercises and vesting of equity awards | | | — | | | — | | | 49,490 | | | — | | | 1,234 | | | — | | | — | | | 1,234 | |
Payment of earn-out liability | | | — | | | — | | | 26,688 | | | — | | | 1,000 | | | — | | | — | | | 1,000 | |
Accumulated other comprehensive income | | | — | | | — | | | — | | | — | | | — | | | — | | | (198 | ) | | (198 | ) |
Balance at September 30, 2023 | | | 17,500 | | $ | 152,928 | | | 30,167,657 | | $ | — | | $ | 524,112 | | $ | (208,915 | ) | $ | (296 | ) | $ | 314,901 | |
The accompanying notes are an integral part of these unaudited condensed consolidated financial statements.
| | | | | | | | | | | | | | | | | | | | | | | | | |
| | | | | | | | | | | | | | Accumulated | | | |
| | Convertible and Redeemable | | | | | | Additional | | | | Other | | Total | |
| | Series A-2 Preferred Stock | | Common Stock | | Paid-In | | Accumulated | | Comprehensive | | Stockholders' | |
| | Shares | | Amount | | Shares | | Amount | | Capital | | Deficit | | Income (Loss) | | Equity | |
Balance at December 31, 2023 | | | 17,500 | | $ | 152,928 | | | 30,190,231 | | $ | — | | $ | 531,831 | | $ | (210,356 | ) | $ | (223 | ) | $ | 321,252 | |
Net loss | | | — | | | — | | | — | | | — | | | — | | | (13,357 | ) | | — | | | (13,357 | ) |
Stock-based compensation | | | — | | | — | | | — | | | — | | | 11,272 | | | — | | | — | | | 11,272 | |
Redemption of Series A-2 Preferred Stock | | | (5,833 | ) | | (60,000 | ) | | — | | | — | | | — | | | — | | | — | | | - | |
Dividend payment to the Series A-2 preferred stockholders | | | — | | | — | | | — | | | — | | | (2,814 | ) | | — | | | — | | | (2,814 | ) |
Common stock issuances pursuant to exercises and vesting of equity awards | | | — | | | — | | | 171,647 | | | — | | | 487 | | | — | | | — | | | 487 | |
Acquisitions consideration paid in common stock | | | — | | | — | | | 220,734 | | | — | | | 6,580 | | | — | | | — | | | 6,580 | |
Payment of earn-out liability | | | — | | | — | | | 35,250 | | | — | | | 1,087 | | | — | | | — | | | 1,087 | |
Accumulated other comprehensive income | | | — | | | — | | | — | | | — | | | — | | | — | | | (35 | ) | | (35 | ) |
Balance at March 31, 2024 | | | 11,667 | | $ | 92,928 | | | 30,617,862 | | $ | — | | $ | 548,443 | | $ | (223,713 | ) | $ | (258 | ) | $ | 324,472 | |
Net loss | | | — | | | — | | | — | | | — | | | — | | | (10,170 | ) | | — | | | (10,170 | ) |
Stock-based compensation | | | — | | | — | | | — | | | — | | | 11,831 | | | — | | | — | | | 11,831 | |
Dividend payment to the Series A-2 preferred shareholders | | | — | | | — | | | — | | | — | | | (2,750 | ) | | — | | | — | | | (2,750 | ) |
Common stock issuances pursuant to exercises and vesting of equity awards | | | — | | | — | | | 39,144 | | | — | | | 888 | | | — | | | — | | | 888 | |
Issuance of common stock pursuant to follow-on offering | | | — | | | — | | | 3,450,000 | | | — | | | 121,776 | | | — | | | — | | | 121,776 | |
Acquisitions consideration paid in common stock | | | — | | | — | | | 61,707 | | | — | | | 2,691 | | | — | | | — | | | 2,691 | |
Accumulated other comprehensive loss | | | — | | | — | | | — | | | — | | | — | | | — | | | 35 | | | 35 | |
Balance at June 30, 2024 | | | 11,667 | | $ | 92,928 | | | 34,168,713 | | $ | — | | $ | 682,879 | | $ | (233,883 | ) | $ | (223 | ) | $ | 448,773 | |
Net loss | | | — | | | — | | | — | | | — | | | — | | | (10,564 | ) | | — | | | (10,564 | ) |
Stock-based compensation | | | — | | | — | | | — | | | — | | | 11,763 | | | — | | | — | | | 11,763 | |
Dividend payment to the Series A-2 preferred shareholders | | | — | | | — | | | — | | | — | | | (2,750 | ) | | — | | | — | | | (2,750 | ) |
Common stock issuances pursuant to exercises and vesting of equity awards | | | — | | | — | | | 96,827 | | | — | | | 598 | | | — | | | — | | | 598 | |
Acquisitions consideration paid in common stock | | | — | | | — | | | 30,953 | | | — | | | 1,441 | | | — | | | — | | | 1,441 | |
Accumulated other comprehensive loss | | | — | | | — | | | — | | | — | | | — | | | — | | | (70 | ) | | (70 | ) |
Balance at September 30, 2024 | | | 11,667 | | $ | 92,928 | | | 34,296,493 | | $ | — | | $ | 693,931 | | $ | (244,447 | ) | $ | (293 | ) | $ | 449,191 | |
The accompanying notes are an integral part of these unaudited condensed consolidated financial statements.
MONTROSE ENVIRONMENTAL GROUP, INC.
UNAUDITED CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS
(In thousands)
| | | | | | | | |
| | For the Nine Months Ended September 30, | |
| | 2024 | | | 2023 | |
Operating activities: | | | | | | |
Net loss | | $ | (34,091 | ) | | $ | (29,418 | ) |
Adjustments to reconcile net loss to net cash provided by operating activities: | | | | | | |
Depreciation and amortization | | | 37,408 | | | | 33,816 | |
Amortization of right-of-use asset | | | 8,423 | | | | 7,667 | |
Stock-based compensation expense | | | 34,866 | | | | 35,609 | |
Fair value changes in financial instruments | | | 4,851 | | | | 1,814 | |
Deferred income taxes | | | 4,931 | | | | 2,842 | |
Other operating activities, net | | | 315 | | | | 2,403 | |
Changes in operating assets and liabilities, net of acquisitions: | | | | | | |
Accounts receivable and contract assets | | | (45,898 | ) | | | (9,538 | ) |
Accounts payable and other accrued liabilities | | | (2,192 | ) | | | (772 | ) |
Accrued payroll and benefits | | | (4,936 | ) | | | 6,092 | |
Payment of contingent consideration | | | — | | | | (611 | ) |
Change in operating leases | | | (9,233 | ) | | | (7,525 | ) |
Other assets | | | (4,165 | ) | | | (907 | ) |
Net cash (used in) provided by operating activities | | | (9,721 | ) | | | 41,472 | |
Investing activities: | | | | | | |
Proceeds from corporate owned and property insurance | | | 182 | | | | 311 | |
Purchases of property and equipment | | | (19,086 | ) | | | (24,969 | ) |
Proceeds from the sale of property and equipment | | | 401 | | | | — | |
Proprietary software development and other software costs | | | (2,052 | ) | | | (2,763 | ) |
Purchase price true ups | | | (3,413 | ) | | | (1,027 | ) |
Minority investments | | | (210 | ) | | | (2,347 | ) |
Cash paid for acquisitions, net of cash acquired | | | (113,012 | ) | | | (66,187 | ) |
Net cash used in investing activities | | | (137,190 | ) | | | (96,982 | ) |
Financing activities: | | | | | | |
Proceeds from line of credit | | | 326,468 | | | | — | |
Repayment of the line of credit | | | (278,335 | ) | | | — | |
Proceeds from the aircraft loan | | | — | | | | 10,935 | |
Repayment of aircraft loan | | | (796 | ) | | | (335 | ) |
Proceeds from term loan | | | 50,000 | | | | — | |
Repayment of term loan | | | (11,094 | ) | | | (8,785 | ) |
Payment of contingent consideration and other purchase price true ups | | | (363 | ) | | | (1,535 | ) |
Repayment of finance leases | | | (4,384 | ) | | | (3,378 | ) |
Payments of deferred financing costs | | | (348 | ) | | | — | |
Proceeds from issuance of common stock for exercised stock options | | | 1,973 | | | | 4,529 | |
Proceeds from issuance of common stock in follow-on offering | | | 121,776 | | | | — | |
Dividend payment to the series A-2 stockholders | | | (8,314 | ) | | | (12,300 | ) |
Repayment to the series A-2 stockholders | | | (60,000 | ) | | | — | |
Net cash provided by (used in) financing activities | | | 136,583 | | | | (10,869 | ) |
Change in cash, cash equivalents and restricted cash | | | (10,328 | ) | | | (66,379 | ) |
Foreign exchange impact on cash balance | | | 133 | | | | (265 | ) |
Cash, cash equivalents and restricted cash: | | | | | | |
Beginning of year | | | 23,240 | | | | 89,828 | |
End of period | | $ | 13,045 | | | $ | 23,184 | |
The accompanying notes are an integral part of these unaudited condensed consolidated financial statements.
| | | | | | | | |
| | For the Nine Months Ended September 30, | |
| | 2024 | | | 2023 | |
Supplemental disclosures of cash flows information: | | | | | | |
Cash paid for interest | | $ | 10,699 | | | $ | 4,838 | |
Cash paid for income tax | | $ | 2,713 | | | $ | 1,374 | |
Supplemental disclosures of non-cash investing and financing activities: | | | | | | |
Accrued purchases of property and equipment | | $ | 1,810 | | | $ | 1,626 | |
Property and equipment purchased under finance leases | | $ | 5,806 | | | $ | 5,728 | |
Common stock issued to acquire new businesses | | $ | 10,712 | | | $ | 2,598 | |
Acquisitions unpaid contingent consideration | | $ | 34,348 | | | $ | 6,369 | |
Acquisitions contingent consideration paid in common stock | | $ | 1,087 | | | $ | 1,000 | |
The accompanying notes are an integral part of these unaudited condensed consolidated financial statements.
MONTROSE ENVIRONMENTAL GROUP, INC.
NOTES TO UNAUDITED CONDENSED CONSOLIDATED FINANCIAL STATEMENTS
(In thousands, except where otherwise indicated)
1. DESCRIPTION OF THE BUSINESS AND BASIS OF PRESENTATION
Description of the Business
Montrose Environmental Group, Inc. (“Montrose” or the “Company”) is a corporation formed on November 2013, under the laws of the State of Delaware. The Company has approximately 120 offices across the United States, Canada, Australia and Europe and approximately 3,480 employees as of September 30, 2024.
Montrose is an environmental services company serving the recurring environmental needs of a diverse client base, including Fortune 500 companies and federal, state and local governments through the following three segments:
Assessment, Permitting and Response segment provides scientific advisory and consulting services to support environmental assessments, environmental emergency response and recovery, toxicology consulting and environmental audits and permits for current operations, facility upgrades, new projects, decommissioning projects and development projects. The Company works closely with clients to navigate the regulatory process at the local, state, provincial and federal levels, to identify the potential environmental and political impacts of their decisions and develop practical mitigation approaches, as needed. In addition to environmental toxicology, and given the Company's expertise in helping businesses plan for and respond to disruptions, the Company's scientists and response teams have helped clients navigate their preparation for and response to emergency response situations.
Measurement and Analysis segment is one of the largest providers of environmental testing and laboratory services in North America. The Company's highly credentialed teams test and analyze air, water and soil to determine concentrations of contaminants, as well as the toxicological impact of contaminants on flora, fauna and human health. The Company's offerings include source and ambient air testing and monitoring, leak detection, and advanced multi-media laboratory services, including air, soil, stormwater, wastewater and drinking water analysis.
Remediation and Reuse segment provides clients with engineering, design, and implementation services, primarily to treat contaminated water, remove contaminants from soil or create biogas from waste. The Company's team, including engineers, scientists and consultants, provides these services to assist clients in designing solutions, managing products and mitigating environmental risks and liabilities at their locations. The Company does not own the properties or facilities at which it implements these projects or the underlying liabilities, nor does the Company own material amounts of the equipment used in projects.
Basis of Presentation
The unaudited condensed consolidated financial statements include the operations of the Company and its wholly-owned subsidiaries. These unaudited condensed consolidated financial statements are presented in conformity with accounting principles generally accepted in the United States (“U.S. GAAP”) and have been prepared pursuant to the rules and regulations of the U.S. Securities and Exchange Commission (“SEC”) that permit reduced disclosure for interim periods. The unaudited condensed consolidated financial statements include all accounts of the Company and, in the opinion of management, include all recurring adjustments and normal accruals necessary for a fair statement of the Company’s financial position, results of operations and cash flows for the dates and periods presented. These unaudited condensed consolidated financial statements should be read in conjunction with the Company’s audited financial statements as of and for the year ended December 31, 2023. Results for interim periods are not necessarily indicative of the results to be expected during the remainder of the current year or for any future period. All intercompany transactions, accounts and profits, have been eliminated in the unaudited condensed consolidated financial statements.
Within the unaudited condensed consolidated financial statements certain amounts in the prior period have been reclassified to conform with current period presentation. The Company reclassified $0.8 million of provision for bad debt, $0.4 million of fair value changes, $2.8 million of deferred income taxes, $0.9 million of prepaid expense and other asset and $1.2 million of other activities to other operating activities, net, in the condensed consolidated statements of cash flows for the nine months ended September 30, 2023. The Company disaggregated 76,178 shares or $2.2 million of common stock issued for quarter ended September 30, 2023, 130,115 shares or $3.2 million of common stock issued for quarter ended June 30, 2023, and 427,631 shares or $8.2 million of common stock issued for quarter ended March 31, 2024 to separate line items on the condensed consolidated statements of convertible and redeemable series A-2 preferred stock and stockholders’ equity. These changes had no effect on the Company's results of operations or financial position.
2. SUMMARY OF NEW ACCOUNTING PRONOUNCEMENTS
Recently Adopted Accounting Pronouncements
In November 2023, the Financial Accounting Standards Board ("FASB") issued Accounting Standard Update ("ASU") 2023-07, Improvements to Reportable Segment Disclosures. The amendments improve reportable segment disclosure requirements, primarily through enhanced disclosures about significant segment expenses. In addition, the amendments enhance interim disclosure requirements, clarify circumstances in which an entity can disclose multiple segment measures of profit or loss, provide new segment disclosure requirements for entities with a single reportable segment, and contain other disclosure requirements. The purpose of the amendments is to enable investors to better understand an entity’s overall performance and assess potential future cash flows. ASU 2023-07 is effective for the Company's fiscal year beginning January 1, 2024 and requires the use of a retrospective approach to all prior periods presented. The Company adopted the standard on January 1, 2024, and plans to adopt the standard for interim periods beginning January 1, 2025. The Company is evaluating the potential impact of its adoption of ASU 2023-07 on the Company's audited Consolidated Financial Statements but does not anticipate that such an adoption will have a material impact.
Recently Issued Accounting Pronouncements Not Yet Adopted
In August 2023, the FASB issued ASU 2023-05, under which an entity that qualifies as either a joint venture or a corporate joint venture is required to apply a new basis of accounting upon the formation of the joint venture. Specifically, the ASU provides that a joint venture or a corporate joint venture must initially measure its assets and liabilities at fair value on the formation date. The amendments in ASU 2023-05 are effective for all joint ventures within the ASU’s scope that are formed on or after January 1, 2025. Early adoption is permitted. The Company is currently evaluating the impact of the adoption of the standard on its consolidated financial statements.
In December 2023, the FASB issued ASU 2023-09, Improvements to Income Tax Disclosures, which improves the transparency of income tax disclosures by requiring consistent categories and greater disaggregation of information in the rate reconciliation and income taxes paid disaggregated by jurisdiction. It also includes certain other amendments to improve the effectiveness of income tax disclosures. ASU 2023-09 is effective for the Company beginning January 1, 2025 and allows the use of a prospective or retrospective approach. The Company is currently evaluating the impact of the adoption of the standard on its consolidated financial statements.
3. REVENUES AND ACCOUNTS RECEIVABLE
The Company’s main revenue sources derive from the following revenue streams:
Assessment, Permitting and Response Revenues—Assessment, Permitting and Response revenues are generated from multidisciplinary environmental consulting services. The majority of the contracts are fixed-price or time and material based.
Measurement and Analysis Revenues—Measurement and Analysis revenues are generated from emissions sampling, testing and reporting services, leak detection services, ambient air monitoring services and laboratory testing services. The majority of the contracts are fixed-price or time-and-materials based.
Remediation and Reuse Revenues—Remediation and Reuse revenues are generated from engineering, design, implementation and operating and maintenance (“O&M”) services primarily to treat contaminated water, remove contaminants from soil or create biogas from waste. Engineering, design and implementation contracts are predominantly fixed-fee and time-and-materials based. Services on the majority of O&M contracts are provided under long-term fixed-fee contracts.
Disaggregation of Revenue—The Company disaggregates revenue by its operating segments. The Company believes disaggregating revenue into these categories achieves the disclosure objectives to depict how the nature, amount, and uncertainty of revenue and cash flows are affected by economic factors. Disaggregated revenue disclosures are provided in Note 19.
Contract Balances—The Company presents contract balances for unbilled receivables (contract assets), as well as customer advances, deposits and deferred revenue (contract liabilities) within contract assets and accounts payable and other accrued expenses, respectively, on the unaudited condensed consolidated statements of financial position. Amounts are generally billed at periodic intervals (e.g. weekly, bi-weekly or monthly) as work progresses in accordance with agreed-upon contractual terms. The Company utilizes the practical expedient to not adjust the promised amount of consideration for the effects of a significant financing component for arrangements in which the period between when the Company transfers services to a customer and when the customer pays for those services is one year or less. Amounts recorded as unbilled receivables are generally for services the Company is not entitled to bill based on the passage of time. Under certain contracts, billing occurs subsequent to revenue recognition, resulting in contract assets. The Company sometimes receives advances or deposits from customers before revenue is recognized, resulting in contract liabilities.
The following table presents the Company’s contract balances:
| | | | | | | | |
| | September 30, | | | December 31, | |
| | 2024 | | | 2023 | |
Contract assets | | $ | 65,553 | | | $ | 51,629 | |
Contract liabilities | | | 11,988 | | | | 8,132 | |
Contract assets acquired through business acquisitions amounted to $2.7 million and $2.2 million as of September 30, 2024 and December 31, 2023, respectively. No material contract liabilities were acquired through business acquisitions as of September 30, 2024 and December 31, 2023.
Revenue recognized during the three and nine months ended September 30, 2024, included in the contract liabilities balance at the beginning of the year was $0.4 million and $5.2 million, respectively. The revenue recognized from the contract liabilities consisted of the Company satisfying performance obligations during the normal course of business.
Remaining Unsatisfied Performance Obligations—Remaining unsatisfied performance obligations represent the total dollar value of work to be performed on fixed fee contracts awarded primarily within our soil remediation and treatment technology (water treatment and renewable energy) business lines. The amount of remaining unsatisfied performance obligations increases with new contracts or additions to existing contracts and decreases as revenue is recognized on existing contracts. Contracts are included in the amount of remaining unsatisfied performance obligations when an enforceable agreement has been reached. As of September 30, 2024 and December 31, 2023, the estimated revenue expected to be recognized in the future related to unsatisfied performance obligations was approximately $78.3 million and $81.9 million, respectively. As of September 30, 2024, the Company expected to recognize approximately $58.0 million of this amount as revenue within one year and $20.3 million the year after.
Accounts Receivable, Net—The Company extends non-interest-bearing trade credit to its customers in the ordinary course of business. Accounts receivable, net consisted of the following:
| | | | | | | | |
| | September 30, 2024 | | | December 31, 2023 | |
Accounts receivable, invoiced | | $ | 155,152 | | | $ | 115,064 | |
Accounts receivable, other | | | 498 | | | | 20 | |
Allowance for doubtful accounts | | | (2,801 | ) | | | (2,724 | ) |
Accounts receivable, net | | $ | 152,849 | | | $ | 112,360 | |
The Company had one and zero customer that exceeded 10.0% of its gross receivables as of September 30, 2024 and December 31, 2023, respectively. For the three and nine months ended September 30, 2024, the Company had no customer who accounted for more than 10% of revenue. During the three and nine months ended September 30, 2023, the Company had one customer who accounted for 10.6% and 10.5% of revenue, respectively. The Company performs ongoing credit evaluations and based on past collection experience, the Company believes that the receivable balances from these largest customers do not represent a significant credit risk.
The allowance for doubtful accounts consisted of the following:
| | | | | | | | | | | | | | | | | | | | |
| | Beginning Balance | | | Bad Debt Expense (Recovery) | | | Charged to Allowance | | | Other(1) | | | Ending Balance | |
Nine months ended September 30, 2024 | | $ | 2,724 | | | $ | (392 | ) | | $ | 18 | | | $ | 451 | | | $ | 2,801 | |
Year ended December 31, 2023 | | | 1,915 | | | | 3,142 | | | | (2,333 | ) | | | — | | | | 2,724 | |
____________________
(1)This amount consists of additions to the allowance due to business acquisitions.
4. PREPAID AND OTHER CURRENT ASSETS
Prepaid and other current assets consisted of the following:
| | | | | | | | |
| | September 30, 2024 | | | December 31, 2023 | |
Deposits | | $ | 1,451 | | | $ | 1,764 | |
Prepaid expenses | | | 10,875 | | | | 8,112 | |
Supplies | | | 3,163 | | | | 3,819 | |
Prepaid and other current assets | | $ | 15,489 | | | $ | 13,695 | |
5. PROPERTY AND EQUIPMENT, NET
Property and equipment, net, consisted of the following:
| | | | | | | | |
| | September 30, 2024 | | | December 31, 2023 | |
Lab and test equipment | | $ | 20,749 | | | $ | 20,341 | |
Vehicles | | | 6,154 | | | | 6,033 | |
Equipment | | | 58,473 | | | | 50,387 | |
Furniture and fixtures | | | 3,140 | | | | 2,963 | |
Leasehold improvements | | | 12,861 | | | | 10,808 | |
Aircraft | | | 12,386 | | | | 12,312 | |
Building | | | 5,748 | | | | 5,748 | |
| | | 119,511 | | | | 108,592 | |
Land | | | 1,089 | | | | 1,089 | |
Construction in progress | | | 10,336 | | | | 3,956 | |
Less: Accumulated depreciation | | | (64,840 | ) | | | (56,812 | ) |
Total property and equipment—net | | $ | 66,096 | | | $ | 56,825 | |
Total depreciation expense included in the unaudited condensed consolidated statements of operations was $2.8 million and $8.7 million for the three and nine months ended September 30, 2024, respectively, and $2.6 million and $7.4 million for the three and nine months ended September 30, 2023, respectively.
6. LEASES
Leases are classified as either finance leases or operating leases based on criteria in ASC 842. The Company has finance leases for its vehicle and equipment leases and operating leases for its real estate space and office equipment leases. The Company’s operating and finance leases generally have original lease terms between 1 year and 15 years, and in some instances include one or more options to renew. The Company includes options to extend the lease term if the options are reasonably certain of being exercised. The Company currently considers some of its renewal options to be reasonably certain to be exercised. Some leases also include early termination options, which can be exercised under specific conditions. The Company does not have material residual value guarantees or restrictive covenants associated with its leases.
Finance and operating lease assets represent the right to use an underlying asset for the lease term, and finance and operating lease liabilities represent the obligation to make lease payments arising from the lease.
The Company calculates the present value of its finance and operating leases using an estimated incremental borrowing rate (“IBR”), which requires judgment. For real estate operating leases, the Company estimates the IBR based on prevailing market rates for collateralized debt in a similar economic environment with similar payment terms and maturity dates commensurate with the terms of the lease. For all other leases, the Company estimates the IBR based on the stated interest rate on the contract. Since many of the inputs used to calculate the rate implicit in the leases are not readily determinable from the lessee’s perspective, the Company does not use the implicit interest rate.
Certain leases contain variable payments, these payments are expensed as incurred and not included in the Company’s operating lease right-of-use ("ROU") assets and operating lease liabilities. These amounts primarily include payments for maintenance, utilities, taxes, and insurance and are excluded from the present value of the Company’s lease obligations.
The Company does not record operating lease ROU assets or operating lease liabilities for leases with an initial term of 12 months or less. The Company also combines lease and non-lease components on all new or modified operating leases into a single lease component for all classes of assets.
When a lease is terminated before the expiration of the lease term, irrespective of whether the lease is classified as a finance lease or an operating lease, the lessee would derecognize the ROU asset and corresponding lease liability. Any difference would be recognized as a gain or loss related to the termination of the lease. Similarly, if a lessee is required to make any payments or receives any consideration when terminating the lease, it would include such amounts in the determination of the gain or loss upon termination.
The components of lease expense were as follows:
| | | | | | | | | |
| | | For the Three Months Ended September 30, | |
| Statement of Operations Location | | 2024 | | | 2023 | |
Operating lease cost | | | | | | | |
Lease cost | Selling, general and administrative expense | | $ | 3,319 | | | $ | 3,157 | |
Variable lease cost | Selling, general and administrative expense | | | 651 | | | | 334 | |
Total operating lease cost | | | $ | 3,970 | | | $ | 3,491 | |
| | | | | | | |
Finance lease cost | | | | | | | |
Amortization of right of use assets | Depreciation and amortization | | $ | 1,496 | | | $ | 1,342 | |
Interest on lease liabilities | Interest expense, net | | | 26 | | | | 156 | |
Total finance lease cost | | | $ | 1,522 | | | $ | 1,498 | |
Total lease cost | | | $ | 5,492 | | | $ | 4,989 | |
| | | | | | | |
| | | For the Nine Months Ended September 30, | |
| Statement of Operations Location | | 2024 | | | 2023 | |
Operating lease cost | | | | | | | |
Lease cost | Selling, general and administrative expense | | $ | 10,421 | | | $ | 8,702 | |
Variable lease cost | Selling, general and administrative expense | | | 1,687 | | | | 959 | |
Total operating lease cost | | | $ | 12,108 | | | $ | 9,661 | |
| | | | | | | |
Finance lease cost | | | | | | | |
Amortization of right of use assets | Depreciation and amortization | | $ | 4,068 | | | $ | 3,925 | |
Interest on lease liabilities | Interest expense, net | | | 425 | | | | 457 | |
Total finance lease cost | | | $ | 4,493 | | | $ | 4,382 | |
Total lease cost | | | $ | 16,601 | | | $ | 14,043 | |
Supplemental cash flows information related to leases was as follows:
| | | | | | | | |
| | For the Nine Months Ended September 30, | |
| | 2024 | | | 2023 | |
Cash paid for amounts included in the measurement of lease liabilities: | | | | | | |
Operating cash flows used in operating leases | | $ | 9,748 | | | $ | 8,558 | |
Operating cash flows used in finance leases | | | 425 | | | | 457 | |
Financing cash flows used in finance leases | | | 4,384 | | | | 3,378 | |
| | | | | | |
Lease liabilities arising from new ROU assets: | | | | | | |
Operating leases | | | 14,676 | | | | 23,087 | |
Finance leases | | | 5,806 | | | | 5,728 | |
Weighted average remaining lease terms and weighted average discount rates were:
| | | | | | | | |
| | September 30, 2024 | |
| | Operating Leases | | | Finance Leases | |
Weighted average remaining lease term (years) | | | 4.4 | | | | 3.5 | |
Weighted average discount rate | | | 4.6 | % | | | 6.6 | % |
| | | | | | |
| | September 30, 2023 | |
| | Operating Leases | | | Finance Leases | |
Weighted average remaining lease term (years) | | | 5.1 | | | | 3.5 | |
Weighted average discount rate | | | 4.6 | % | | | 6.1 | % |
The following is a schedule by year of the maturities of lease liabilities with original terms in excess of one year:
| | | | | | | | |
| | Operating Leases | | | Finance Leases | |
Remainder of 2024 | | $ | 3,685 | | | $ | 1,382 | |
2025 | | | 12,902 | | | | 4,676 | |
2026 | | | 10,647 | | | | 3,999 | |
2027 | | | 7,684 | | | | 2,983 | |
2028 | | | 6,050 | | | | 1,733 | |
2029 and thereafter | | | 7,444 | | | | 520 | |
Total undiscounted future minimum lease payments | | $ | 48,412 | | | $ | 15,293 | |
Less imputed interest | | | (5,173 | ) | | | (1,683 | ) |
Total discounted future minimum lease payments | | $ | 43,239 | | | $ | 13,610 | |
7. BUSINESS ACQUISITIONS
In line with the Company’s strategic growth initiatives, the Company acquired certain businesses during the nine months ended September 30, 2024 and during the year ended December 31, 2023. The results of each of those acquired businesses are included in the unaudited condensed consolidated financial statements beginning on the respective acquisition date. Each transaction qualified as an acquisition of a business and was accounted for as a business combination.
The Company may be required to make up to $58.6 million in aggregate earn-out payments between the years 2024 and 2026 in connection with certain of its business acquisitions, of which up to $23.4 million may be paid only in cash, up to $13.1 million may be paid only in common stock and up to $22.1 million may be paid, at the Company’s option, in cash or common stock.
Transaction costs related to business combinations totaled $2.8 million and $6.4 million for the three and nine months ended September 30, 2024, respectively, and $1.5 million and $5.0 million for the three and nine months ended September 30, 2023, respectively. These costs are expensed within selling, general and administrative expense in the accompanying unaudited condensed consolidated statements of operations.
Acquisitions Completed During the Nine Months Ended September 30, 2024
Epic Environmental Pty LTD (“EPIC”)—In January 2024, the Company completed the acquisition of EPIC by acquiring 100% of its common stock. EPIC is an environmental consultancy, based in Brisbane, Australia, and serving clients across Australia.
Two Dot Consulting, LLC (“2DOT”)—In February 2024, the Company completed the acquisition of 2DOT by acquiring 100% of its membership interests. 2DOT is a leading environmental consultancy in the Rocky Mountain and adjacent regions, and is based in Denver, Colorado.
Engineering & Technical Associates, Inc. ("ETA")—In April 2024, the Company acquired substantially all of the assets of ETA. ETA is a niche consulting firm focusing on providing process safety management, process hazardous analysis, and other safety-focused services to industrial clients throughout the United States.
Paragon Soil and Environmental Consulting Inc. (“Paragon”)—In May 2024, the Company completed the acquisition of Paragon by acquiring 100% of its ownership and interest. Paragon is an environmental consulting firm that provides services for clients across western Canada.
Spirit Environmental, LLC. ("Spirit")—In July 2024, the Company completed the acquisition of Spirit by acquiring 100% of its membership interests. Spirit is a leading environmental consultant specializing in air permitting and compliance services across the central U.S. Spirit is based in Houston, Texas.
Origins Laboratory, Inc. ("Origins")—In September 2024, the Company acquired substantially all of the assets of Origins. Origins is an accredited environmental analytical testing laboratory based in Denver, Colorado.
The following table summarizes the elements of the preliminary purchase price of the acquisitions completed during the nine months ended September 30, 2024:
| | | | | | | | | | | | | | | | | | | | |
| | Cash | | | Common Stock | | | Other Purchase Price Components | | | Contingent Consideration | | | Total Purchase Price | |
EPIC | | $ | 19,914 | | | $ | 4,748 | | | $ | 587 | | | $ | 11,113 | | | $ | 36,362 | |
2DOT | | | 39,393 | | | | 1,832 | | | | (1,036 | ) | | | — | | | | 40,189 | |
ETA | | | 1,600 | | | | — | | | | 400 | | | | — | | | | 2,000 | |
Paragon | | | 10,982 | | | | 2,691 | | | | (100 | ) | | | — | | | | 13,573 | |
Spirit | | | 16,027 | | | | 1,441 | | | | (333 | ) | | | 10,259 | | | | 27,394 | |
Origins | | | 27,414 | | | | — | | | | — | | | | 8,000 | | | | 35,414 | |
Total | | $ | 115,330 | | | $ | 10,712 | | | $ | (482 | ) | | $ | 29,372 | | | $ | 154,932 | |
The upfront cash payment made to acquire the acquisitions completed during the nine months ended September 30, 2024 was funded through cash on hand and borrowings under our revolving credit facility. The other purchase price components mainly consist of deferred purchase price liabilities and surplus or deficit working capital amounts.
The preliminary purchase price attributable to the acquisitions was allocated as follows:
| | | | | | | | | | | | | | | | | | | | | | | | | | | | |
| | EPIC | | | 2DOT | | | ETA | | | Paragon | | | Spirit | | | Origins | | | Total(1) | |
Cash | | $ | 1,045 | | | $ | 143 | | | $ | — | | | $ | 451 | | | $ | 680 | | | $ | — | | | $ | 2,319 | |
Accounts receivable and contract assets | | | 1,772 | | | | 740 | | | | — | | | | 3,212 | | | | 2,395 | | | | — | | | | 8,119 | |
Other current assets | | | 78 | | | | — | | | | — | | | | 85 | | | | 120 | | | | — | | | | 283 | |
Current assets | | $ | 2,895 | | | $ | 883 | | | $ | — | | | $ | 3,748 | | | $ | 3,195 | | | $ | 0 | | | $ | 10,721 | |
Property and equipment | | | 43 | | | | — | | | | — | | | | 330 | | | | 145 | | | | 1,787 | | | | 2,305 | |
Operating lease right-of-use asset | | | 1 | | | | 301 | | | | — | | | | 1,798 | | | | 693 | | | | 552 | | | | 3,345 | |
Customer relationships | | | 12,327 | | | | 9,521 | | | | — | | | | — | | | | — | | | | — | | | | 21,848 | |
Trade names | | | 652 | | | | 200 | | | | — | | | | — | | | | — | | | | — | | | | 852 | |
Covenants not to compete | | | 1,365 | | | | 2,940 | | | | — | | | | — | | | | — | | | | — | | | | 4,305 | |
Goodwill | | | 20,842 | | | | 26,929 | | | | 2,000 | | | | 10,641 | | | | 24,851 | | | | 33,627 | | | | 118,890 | |
Total assets | | $ | 38,125 | | | $ | 40,774 | | | $ | 2,000 | | | $ | 16,517 | | | $ | 28,884 | | | $ | 35,966 | | | $ | 162,266 | |
Current liabilities | | | 1,763 | | | | 392 | | | | — | | | | 1,383 | | | | 1,490 | | | | — | | | | 5,028 | |
Operating lease liability—net of current portion | | | — | | | | 193 | | | | — | | | | 1,513 | | | | — | | | | 552 | | | | 2,258 | |
Other non-current liabilities | | | — | | | | — | | | | — | | | | 48 | | | | — | | | | — | | | | 48 | |
Total liabilities | | $ | 1,763 | | | $ | 585 | | | $ | — | | | $ | 2,944 | | | $ | 1,490 | | | $ | 552 | | | $ | 7,334 | |
Purchase price | | $ | 36,362 | | | $ | 40,189 | | | $ | 2,000 | | | $ | 13,573 | | | $ | 27,394 | | | $ | 35,414 | | | $ | 154,932 | |
___________________________________
(1) The Company is continuing to obtain information to complete the valuation of certain of these acquisitions' assets and liabilities.
For the acquisitions completed during the nine months ended September 30, 2024, the results of operations since the acquisition dates have been combined with those of the Company. The Company’s unaudited condensed consolidated statement of operations for the three and nine months ended September 30, 2024 includes revenue of $15.0 million and $26.6 million, respectively, and pre-tax income of $3.0 million and $5.4 million, respectively, related to these acquisitions.
For the acquisitions completed during the nine months ended September 30, 2023, the results of operations since the acquisition dates have been combined with those of the Company. The Company’s unaudited condensed consolidated statement of operations for the three and nine months ended September 30, 2023 includes revenue of $29.2 million and $40.8 million, respectively, and pre-tax income of $6.5 million and $7.4 million, respectively, related to these acquisitions.
During the nine months ended September 30, 2024, measurement period adjustments of $52.3 million were recorded to goodwill as a result of the Company’s efforts to complete the valuation of certain acquired assets and assumed liabilities (Note 8).
Supplemental Unaudited Pro-Forma—The unaudited condensed consolidated financial information summarized in the following table gives effect to the 2024 acquisitions discussed above and all acquisitions completed in 2023 assuming they occurred on January 1, 2023. These unaudited consolidated pro-forma operating results do not assume any impact from revenue, cost or other operating synergies that are expected or may have been realized as a result of the acquisitions. These unaudited consolidated pro-forma operating results are presented for illustrative purposes only and are not indicative of the operating results that would have been achieved had the acquisitions occurred on January 1, 2023 nor does the information purport to reflect results for any future period.
| | | | | | | | | | | | | | | | | | | | | | | | |
| | For the Three Months Ended September 30, | |
| | 2024 | | | 2023 | |
| | As reported | | | Acquisitions Pro-Forma (Unaudited) | | | Consolidated Pro-Forma (Unaudited) | | | As reported | | | Acquisitions Pro-Forma (Unaudited) | | | Consolidated Pro-Forma (Unaudited) | |
Revenues | | $ | 178,687 | | | $ | 2,623 | | | $ | 181,310 | | | $ | 167,937 | | | $ | 13,985 | | | $ | 181,922 | |
Net (loss) income | | $ | (10,564 | ) | | $ | 1,583 | | | $ | (8,981 | ) | | $ | (7,525 | ) | | $ | 2,288 | | | $ | (5,237 | ) |
| | | | | | | | | | | | | | | | | | |
| | For the Nine Months Ended September 30, | |
| | 2024 | | | 2023 | |
| | As reported | | | Acquisitions Pro-Forma (Unaudited) | | | Consolidated Pro-Forma (Unaudited) | | | As reported | | | Acquisitions Pro-Forma (Unaudited) | | | Consolidated Pro-Forma (Unaudited) | |
Revenues | | $ | 507,337 | | | $ | 23,225 | | | $ | 530,562 | | | $ | 458,466 | | | $ | 65,798 | | | $ | 524,264 | |
Net (loss) income | | $ | (34,091 | ) | | $ | 8,672 | | | $ | (25,419 | ) | | $ | (29,418 | ) | | $ | 8,110 | | | $ | (21,308 | ) |
8. GOODWILL AND INTANGIBLE ASSETS
Amounts related to goodwill are as follows:
| | | | | | | | | | | | | | | | |
| | Assessment, Permitting and Response | | | Measurement and Analysis | | | Remediation and Reuse | | | Total | |
Balance as of December 31, 2023 | | $ | 184,946 | | | $ | 93,890 | | | $ | 85,613 | | | $ | 364,449 | |
Goodwill acquired during the period | | | 26,851 | | | | 33,627 | | | | 109,813 | | | | 170,291 | |
Acquisitions measurement period adjustments | | | — | | | | — | | | | (51,401 | ) | | | (51,401 | ) |
Prior year acquisitions measurement period adjustments | | | — | | | | — | | | | (866 | ) | | | (866 | ) |
Foreign currency translation impact | | | — | | | | — | | | | 134 | | | | 134 | |
Balance as of September 30, 2024 | | $ | 211,797 | | | $ | 127,517 | | | $ | 143,293 | | | $ | 482,607 | |
Amounts related to finite-lived intangible assets are as follows:
| | | | | | | | | | | | |
September 30, 2024 | | Gross Balance | | | Accumulated Amortization | | | Total Intangible Assets—Net | |
Customer relationships | | $ | 249,938 | | | $ | 132,269 | | | $ | 117,669 | |
Covenants not to compete | | | 40,596 | | | | 32,978 | | | | 7,618 | |
Trade names | | | 25,281 | | | | 22,718 | | | | 2,563 | |
Proprietary software | | | 27,762 | | | | 22,938 | | | | 4,824 | |
Patent | | | 17,479 | | | | 5,501 | | | | 11,978 | |
Total other intangible assets, net | | $ | 361,056 | | | $ | 216,404 | | | $ | 144,652 | |
| | | | | | | | | |
December 31, 2023 | | Gross Balance | | | Accumulated Amortization | | | Total Intangible Assets—Net | |
Customer relationships | | $ | 227,986 | | | $ | 116,226 | | | $ | 111,760 | |
Covenants not to compete | | | 36,250 | | | | 30,889 | | | | 5,361 | |
Trade names | | | 24,434 | | | | 20,719 | | | | 3,714 | |
Proprietary software | | | 26,486 | | | | 19,309 | | | | 7,177 | |
Patent | | | 17,479 | | | | 4,678 | | | | 12,801 | |
Total other intangible assets, net | | $ | 332,635 | | | $ | 191,821 | | | $ | 140,813 | |
Intangible assets with finite lives are stated at cost, less accumulated amortization and impairment losses, if any. These intangible assets are amortized using the straight-line method over the estimated useful lives of the assets.
Amortization expense was $9.0 million and $24.6 million for the three and nine months ended September 30, 2024, respectively, and $8.0 million and $22.5 million for the three and nine months ended September 30, 2023, respectively.
Future amortization expense is estimated to be as follows for each of the five following years and thereafter:
| | | | |
December 31, | | | |
2024 (remaining) | | $ | 7,533 | |
2025 | | | 25,348 | |
2026 | | | 20,031 | |
2027 | | | 19,151 | |
2028 | | | 16,004 | |
Thereafter | | | 56,585 | |
Total | | $ | 144,652 | |
9. ACCOUNTS PAYABLE AND OTHER ACCRUED LIABILITIES
Accounts payable and other accrued liabilities consisted of the following:
| | | | | | | | |
| | September 30, 2024 | | | December 31, 2023 | |
Accounts payable | | $ | 26,727 | | | $ | 31,053 | |
Accrued expenses | | | 14,880 | | | | 16,059 | |
Other business acquisitions purchase price obligations | | | 350 | | | | 1,022 | |
Contract liabilities | | | 11,988 | | | | 8,132 | |
Other current liabilities | | | 3,634 | | | | 3,654 | |
Total accounts payable and other accrued liabilities | | $ | 57,579 | | | $ | 59,920 | |
10. ACCRUED PAYROLL AND BENEFITS
Accrued payroll and benefits consisted of the following:
| | | | | | | | |
| | September 30, 2024 | | | December 31, 2023 | |
Accrued bonuses | | $ | 9,900 | | | $ | 18,453 | |
Accrued paid time off | | | 5,341 | | | | 1,316 | |
Accrued payroll | | | 12,542 | | | | 11,814 | |
Accrued other | | | 3,773 | | | | 3,077 | |
Total accrued payroll and benefits | | $ | 31,556 | | | $ | 34,660 | |
11. INCOME TAXES
The Company calculates its interim income tax provision in accordance with ASC Topic 270, Interim Reporting (“ASC 270”), and ASC 740. The Company’s effective tax rate (“ETR”) from continuing operations was 14.9% and 15.1% for the three and nine months ended September 30, 2024, respectively, and 21.3 % and 10.7 % for the three and nine months ended September 30, 2023, respectively. Income tax expense recorded by the Company during the three and nine months ended September 30, 2024 was $1.4 million and $4.5 million, respectively. Income tax expense recorded by the Company during the three and nine months ended September 30, 2023 was $1.3 million and $2.8 million, respectively. The difference between the ETR and federal statutory rate of 21.0% is primarily attributable to items recorded for U.S. GAAP but permanently disallowed for U.S. federal income tax purposes, recognition of a U.S. federal and state valuation allowance and state and foreign income tax provisions.
A valuation allowance is recorded when it is more-likely-than-not some of the Company’s deferred tax assets may not be realized. Significant judgment is applied when assessing the need for a valuation allowance and the Company considers future taxable income, reversals of existing deferred tax assets and liabilities and ongoing prudent and feasible tax planning strategies, in making such assessment. As of September 30, 2024, the Company’s U.S. federal, state and various foreign net deferred tax assets are not more-likely-than-not to be realized and a full valuation allowance is maintained.
The Company records uncertain tax positions in accordance with ASC 740, on the basis of a two-step process in which (i) the Company determines whether it is more likely than not a tax position will be sustained on the basis of the technical merits of such position and (ii) for those tax positions meeting the more-likely-than-not recognition threshold, the Company would recognize the largest amount of tax benefit that is more than 50.0% likely to be realized upon ultimate settlement with the related tax authority. The Company has determined it has no uncertain tax positions as of September 30, 2024. The Company classifies interest and penalties recognized on uncertain tax positions as a component of income tax expense.
12. DEBT
Debt consisted of the following:
| | | | | | | | |
| | September 30, 2024 | | | December 31, 2023 | |
Term loan facility | | $ | 193,125 | | | $ | 154,219 | |
Revolving line of credit | | | 48,271 | | | | — | |
Aircraft loan | | | 9,547 | | | | 10,344 | |
Less deferred debt issuance costs | | | (1,183 | ) | | | (1,379 | ) |
Total debt | | $ | 249,760 | | | $ | 163,184 | |
Less current portion of long-term debt | | | (16,753 | ) | | | (14,196 | ) |
Long-term debt, less current portion | | $ | 233,007 | | | $ | 148,988 | |
Deferred Financing Costs—Costs relating to debt issuance have been deferred and are presented as discounted against the underlying debt instrument. These costs are amortized to interest expense over the terms of the underlying debt instruments.
2021 Credit Facility—On April 27, 2021, the Company entered into a Senior Secured Credit Agreement providing for a $300.0 million credit facility comprised of a $175.0 million term loan and a $125.0 million revolving line of credit (the “2021 Credit Facility”), and used a portion of the proceeds from the 2021 Credit Facility to repay all amounts outstanding under the prior credit facility. The revolving line of credit portion of the 2021 Credit Facility includes a $20.0 million sublimit for the issuance of letters of credit. Subject to certain exceptions, all amounts under the 2021 Credit Facility will become due on April 27, 2026
. The Company has the option to borrow incremental term loans or request an increase in the aggregate commitments under the revolving credit facility up to an aggregate amount of $150.0 million subject to the satisfaction of certain conditions.
In January 2024, the Company partially exercised its option to request an increase in the aggregate commitments to provide an additional $100.0 million credit availability under the 2021 Credit Facility, comprised of an additional $50.0 million term loan ("Additional Term Loan") and an additional $50.0 million in availability under the revolving line of credit.
The 2021 Credit Facility term loan must be repaid in quarterly installments and shall amortize at the following future quarterly rates:
| | |
| Quarterly Installment Rate |
Date | 2021 Credit Facility Term Loan | Additional Term Loan |
December 31, 2024 | 1.88% | 1.25% |
March 31, 2025 | 1.88% | 1.25% |
June 30, 2025 | 1.88% | 1.25% |
September 30, 2025 | 1.88% | 1.25% |
December 31, 2025 | 2.50% | 1.25% |
March 31, 2026 | 2.50% | 1.88% |
April 27, 2026 | Remaining balance | Remaining balance |
Exclusive of the repayment made related to quarter ended June 30, 2024, which was made in the current quarter, the quarterly installment repayments for the three months ended September 30, 2024 were $3.9 million. Installment repayments for the nine months ended September 30, 2024 were $11.1 million. Quarterly installment repayments for the three and nine months ended September 30, 2023 were $2.2 million and $6.6 million, respectively.
On May 31, 2023, the Company amended its 2021 Credit Facility agreement to transition the reference rate from LIBOR to SOFR. The transition to SOFR did not materially impact the interest rate paid by the Company or change any material terms of the 2021 Credit Facility.
The 2021 Credit Facility term loan and the revolving line of credit bear interest subject to the applicable spread based on Company’s leverage ratio and SOFR plus 0.10% as follows:
| | | | | | | | | | | | | | | | | | | |
Pricing Tier | | Consolidated Leverage Ratio | | Senior Credit Facilities SOFR Spread | | | Senior Credit Facilities Base Rate Spread | | | Commitment Fee | | | Letter of Credit Fee | | |
1 | | ≥ 3.75x to 1.0 | | | 2.50 | | % | | 1.50 | | % | | 0.25 | | % | | 2.50 | | % |
2 | | < 3.75x to 1.0 but ≥ 3.25 to 1.0 | | | 2.25 | | | | 1.25 | | | | 0.23 | | | | 2.25 | | |
3 | | <3.25x to 1.0 but ≥ 2.50 to 1.0 | | | 2.00 | | | | 1.00 | | | | 0.20 | | | | 2.00 | | |
4 | | <2.50x to 1.0 but ≥ 1.75 to 1.0 | | | 1.75 | | | | 0.75 | | | | 0.15 | | | | 1.75 | | |
5 | | <1.75x to 1.0 | | | 1.50 | | | | 0.50 | | | 0.15 | | | | 1.50 | | |
On May 30, 2023, the Company amended the interest rate swap transaction it entered into on January 27, 2022 (the "2022 Interest Rate Swap"), to convert the floating component of the interest rate on $100.0 million of borrowings to 1-Month Term SOFR and a new coupon of 1.319% until January 27, 2025. Prior to the amendment, the floating component of the interest rate was subject to LIBOR and a coupon of 1.39%. The transition to SOFR did not materially impact the interest rate paid by the Company or change any material terms of the 2022 Interest Rate Swap.
On May 30, 2023, the Company entered into a second interest rate swap transaction, fixing the floating component of the interest rate on an additional $70.0 million of borrowings to 1-Month Term SOFR and a coupon of 3.88% until April 27, 2026.
On June 5, 2024, the Company transitioned the 2022 Interest Rate Swap agreement of $100.0 million to a three-year term on $80.0 million of borrowings, with a fixed SOFR rate of 3.27%.
The 2021 Credit Facility includes a number of covenants imposing certain restrictions on the Company’s business, including, among other things,
restrictions on the Company’s ability, subject to certain exceptions and baskets, to incur indebtedness, incur liens on its assets, agree to any additional negative pledges, pay dividends or repurchase stock, limit the ability of its subsidiaries to pay dividends or distribute assets, make investments, enter into any transaction of merger or consolidation, liquidate, wind-up or dissolve, or convey any part of its business, assets or property, or acquire the business, property or assets of another person, enter into sale and leaseback transactions, enter into certain transactions with affiliates, engage in any material line of business substantially different from those engaged on the closing date, modify the terms of indebtedness subordinated to the loans incurred under the 2021 Credit Facility and modify the terms of its organizational documents. The 2021 Credit Facility also includes financial covenants which required the Company to remain below a maximum total net leverage ratio of 4.25 times until the fiscal quarter ended September 31, 2022, which stepped down to 4.00 times during the fiscal quarter ending December 31, 2022 and applies through and including the fiscal quarter ending September 30, 2023 and then further steps down to 3.75 times beginning with the fiscal quarter ending December 31, 2023, and a minimum fixed charge coverage ratio of 1.25 times. In January, 2024, the Company exercised its credit facility covenant holiday, increasing its leverage capacity from 3.75 times to 4.25 times for four quarters beginning with the first quarter of 2024.
As of September 30, 2024 and December 31, 2023, the Company’s consolidated total leverage ratio (as defined in the 2021 Credit Facility) was 2.6 times and 1.9 times, respectively, and the Company was in compliance with all covenants under the 2021 Credit Facility.
The 2021 Credit Facility requires customary mandatory prepayments of the term loan and revolver and cash collateralization of letters of credit, subject to customary exceptions, including 100.0% of the proceeds of debt not permitted by the 2021 Credit Facility, 100.0% of the proceeds of certain dispositions, subject to customary reinvestment rights, where applicable, and 100.0% of insurance or condemnation proceeds, subject to customary reinvestment rights, where applicable. The 2021 Credit Facility also includes customary events of default and related acceleration and termination rights.
The weighted average interest rate on the 2021 Credit Facility for the nine months ended September 30, 2024 and September 30, 2023, before giving effect to the impact of the interest rate swaps, was 7.2% and 6.6%, respectively, and after giving effect to the impact of the interest rate swaps, was 2.8%, and 2.4%, respectively.
The Company’s obligations under the 2021 Credit Facility are guaranteed by certain of the Company’s existing and future direct and indirect subsidiaries, and such obligations are secured by substantially all of the Company’s assets, including the capital stock or other equity interests in those subsidiaries.
Loan and Aircraft Security Agreement—On May 18, 2023, the Company entered into a Loan and Aircraft Security Agreement to finance $10.9 million of the purchase a new aircraft (the "Aircraft Loan"). The Aircraft Loan must be repaid in 60 monthly consecutive installments and all outstanding amounts will become due on May 18, 2028. The Aircraft Loan bears interest subject to 1-Month Term SOFR and a coupon of 1.86%. The entire principal balance may be prepaid in full subject to a 3.0%, 2.0% and 1.0% prepayment fee if paid prior to the first, second and third anniversary of the loan, respectively. The aircraft serves as collateral security for the Aircraft Loan.
Equipment Line of Credit—In May 2024, the Company entered into a $15.0 million equipment leasing facility for the purchase of equipment and related freight, installation costs and taxes paid. Any unused capacity on this equipment leasing facility will expire on April 15, 2025. Interest on leases financed under this facility is based on the SOFR swap rate on or closest to the closing date. Equipment leased through this line of credit met the finance lease criteria as per ASC 842 and accordingly is accounted for as finance lease right-of-use assets and finance lease liabilities.
The following is a schedule of the aggregate annual maturities of long-term debt presented on the unaudited condensed consolidated statement of financial position, gross of deferred debt issuance cost of $1.2 million, based on the terms of the 2021 Credit Facility and the Aircraft Loan:
| | | | | | | | | | | | | |
| | 2021 Credit Facility | | | | | |
September 30, | | Term Loan | | Revolver | | Aircraft Loan | | Total | |
2025 | | $ | 15,625 | | $ | — | | $ | 1,128 | | $ | 16,753 | |
2026 | | | 177,500 | | | 48,271 | | | 1,209 | | | 226,980 | |
2027 | | | — | | | — | | | 1,295 | | | 1,295 | |
2028 | | | — | | | — | | | 5,915 | | | 5,915 | |
Total | | $ | 193,125 | | $ | 48,271 | | $ | 9,547 | | $ | 250,943 | |
13. FAIR VALUE OF FINANCIAL INSTRUMENTS
The following financial instruments are measured at fair value on a recurring basis using significant unobservable inputs (Level 3):
| | | | | | | |
| September 30, 2024 | | | December 31, 2023 | |
Interest rate swap (1) | $ | — | | | $ | 3,461 | |
Total Assets | $ | — | | | $ | 3,461 | |
| | | | | |
Business acquisitions contingent consideration, current | $ | 6,423 | | | $ | 3,592 | |
Business acquisitions contingent consideration, long-term | | 27,924 | | | | 2,448 | |
Conversion option related to Series A-2 Preferred Stock | | 20,054 | | | | 19,017 | |
Interest rate swap (1) | | 353 | | | | — | |
Total Liabilities | $ | 54,754 | | | $ | 25,057 | |
_____________________________
(1) Included in other assets and other non-current liabilities in the unaudited condensed consolidated statement of financial position as of September 30, 2024 and December 31, 2023, respectively.
The estimated fair value amounts shown above are not necessarily indicative of the amounts that the Company would realize upon disposition, nor do they indicate the Company’s intent or ability to dispose of the financial instrument.
The following table sets forth the Company’s financial instruments that were measured at fair value on a recurring basis:
| | | | | | | | | | | | | | | | | | | | | | | |
| Interest Rate Swap | | | Total Assets | | | Business Acquisitions Contingent Consideration, Current | | | Business Acquisitions Contingent Consideration, Long-term | | | Conversion Option Related to Series A-2 Preferred Stock | | | Total Liabilities | |
Balance as of December 31, 2022 | $ | 6,046 | | | $ | 6,046 | | | $ | 3,801 | | | $ | 4,454 | | | $ | 25,731 | | | $ | 33,986 | |
Acquisitions | | — | | | | — | | | | 397 | | | | 730 | | | | — | | | | 1,127 | |
Changes in fair value included in earnings | | 283 | | | | 283 | | | | (73 | ) | | | 206 | | | | 2,097 | | | | 2,230 | |
Payment of contingent consideration payable | | — | | | | — | | | | (3,146 | ) | | | — | | | | — | | | | (3,146 | ) |
Reclass of long term to short term contingent liabilities | | — | | | | — | | | | 2,260 | | | | (2,260 | ) | | | — | | | | — | |
Balance as of September 30, 2023 | $ | 6,329 | | | $ | 6,329 | | | $ | 3,239 | | | $ | 3,130 | | | $ | 27,828 | | | $ | 34,197 | |
| | | | | | | | | | | | | | | | | |
Balance as of December 31, 2023 | $ | 3,461 | | | $ | 3,461 | | | $ | 3,592 | | | $ | 2,448 | | | $ | 19,017 | | | $ | 25,057 | |
Acquisitions | | — | | | | — | | | | 4,976 | | | | 24,396 | | | | — | | | | 29,372 | |
Changes in fair value included in earnings | | (3,814 | ) | | | (3,814 | ) | | | 131 | | | | 254 | | | | 1,037 | | | | 1,422 | |
Reclass of asset to liability due to fair value change | | — | | | | 353 | | | | — | | | | — | | | | — | | | | 353 | |
Payment of contingent consideration payable | | — | | | | — | | | | (1,450 | ) | | | — | | | | — | | | | (1,450 | ) |
Reclass of long term to short term contingent liabilities | | — | | | | — | | | | (826 | ) | | | 826 | | | | — | | | | — | |
Balance as of September 30, 2024 | $ | (353 | ) | | $ | — | | | $ | 6,423 | | | $ | 27,924 | | | $ | 20,054 | | | $ | 54,754 | |
14. COMMITMENTS AND CONTINGENCIES
Leases—The Company leases office facilities over various terms expiring through 2034. Certain of these operating leases contain rent escalation clauses. The Company also has office equipment leases that expire through 2029 (Note 6 and 12).
Other Commitments—The Company has commitments under the 2021 Credit Facility, its Aircraft Loan, its equipment line of credit and its lease obligations (Note 6 and 12). The Company has entered into a purchase contract to purchase a total of $4.9 million of equipment over the course of 7 years that commenced on July 1, 2024, subject to a minimum spending requirement per year, measured from the commencement date and each anniversary thereof. The minimum spend requirement is $0.2 million, $0.4 million, and $0.9 million for 2025, 2026, and 2027, respectively, with the remainder subject to mutual agreement after the first three years. The amount purchased for the three and nine months ended September 30, 2024 was $0.
Contingencies—The Company is subject to purchase price contingencies related to earn-outs associated with certain acquisitions (Note 7 and 13).
Legal—In the normal course of business, the Company is at times subject to pending and threatened legal actions. In management’s opinion, the potential loss resulting from the resolution of these matters is not expected to have a material effect on the unaudited condensed consolidated results of operations, financial position or cash flows of the Company.
15. CONVERTIBLE AND REDEEMABLE SERIES A-2 PREFERRED STOCK
On April 13, 2020, the Company entered into an agreement to issue 17,500 shares of the Convertible and Redeemable Series A-2 Preferred Stock with a par value of $0.0001 per share and a detachable warrant to purchase shares of the Company’s common stock with a 10-year life, in exchange for gross proceeds of $175.0 million, net of $1.3 million debt issuance costs. The Convertible and Redeemable Series A-2 Preferred Stock warrants were exercised in full on July 30, 2020. The Company paid dividends on shares of the Convertible and Redeemable Series A-2 Preferred Stock of $2.8 million and $4.1 million during the three months ended September 30, 2024 and September 30, 2023, and $8.3 million and $12.3 million during the nine months ended September 30, 2024 and September 30, 2023, respectively.
The Convertible and Redeemable Series A-2 Preferred Stock terms include the following: (i) no mandatory redemption, (ii) no stated value cash repayment obligation other than in the event of certain defined liquidation events, (iii) only redeemable at the Company’s option, (iv) convertible into common stock beginning in April 2024 at a 15.0% discount to the common stock market price (with a limit of $60.0 million in stated value of Convertible and Redeemable Series A-2 Preferred Stock eligible to be converted in any 60-day period prior to the seventh anniversary of issuance and the amount of stated value of the Convertible and Redeemable Series A-2 Preferred Stock eligible for conversion limited to $60.0 million during year 5 and $120.0 million (which includes the aggregate amount of the stated value of the Convertible and Redeemable Series A-2 Preferred Stock and any accrued but unpaid dividends added to such stated value of any shares of Convertible and Redeemable Series A-2 Preferred Stock converted in year 5) during year 6), (v) 9.0% dividend rate per year with required quarterly cash payments, (vi) in an event of noncompliance, the dividend rate shall increase to 12.0% per annum for the first 90-day period from and including the date the noncompliance event occurred, and thereafter shall increase to 14.0% per annum, (vii) debt incurrence test ratio of 4.5 times, and (viii) minimum repayment amount of $25.0 million.
The Company may, at its option on any one or more dates, redeem all or a minimum portion (the lesser of (i) $25.0 million in aggregate stated value of the Convertible and Redeemable Series A-2 Preferred Stock and (ii) all of the Convertible and Redeemable Series A-2 Preferred Stock then outstanding) of the outstanding Convertible and Redeemable Series A-2 Preferred Stock in cash. In January 2024, the Company redeemed $60 million of the outstanding Convertible and Redeemable Series A-2 Preferred Stock with cash. As of September 30, 2024, the aggregate amount of the Convertible and Redeemable Series A-2 Preferred Stock issued and outstanding was $122.2 million, or 11,667 shares.
The Convertible and Redeemable Series A-2 Preferred Stock does not meet the definition of a liability pursuant to “ASC 480- Distinguishing Liabilities from Equity.” However, as (i) the instrument is redeemable upon a change of control as defined in the certificate of designations governing the terms of the Convertible and Redeemable Series A-2 Preferred Stock, and (ii) the Company cannot assert it would have sufficient authorized and unissued shares of common stock to settle all future conversion requests due to the variable conversion terms, the instrument is redeemable upon the occurrence of events that are not solely within the control of the Company, and therefore the Company classifies the Convertible and Redeemable Series A-2 Preferred Stock as mezzanine equity. Subsequent adjustment of the carrying value of the instrument is required if the instrument is probable of becoming redeemable. As of September 30, 2024, the Company has determined that a change of control is not probable. Additionally, as of September 30, 2024, the Company has determined that it is not probable that there will be a future conversion request that the Company is unable to settle with authorized and issued shares based on the Company’s current stock price and available shares as well as the Company’s monitoring efforts to ensure there are a sufficient number of shares available to settle any conversion request. Therefore, as of September 30, 2024, the Company has determined that the instrument is not probable of becoming redeemable, and does not believe subsequent adjustment of the carrying value of the instrument will be necessary.
The Convertible and Redeemable Series A-2 Preferred Stock contains a conversion option of the preferred stock to shares of common stock beginning on the fourth-year anniversary of the issuance date. As of September 30, 2024 and December 31, 2023, this conversion embedded feature had a net fair value of $20.1 million and $19.0 million, respectively. The change in net fair value of $0.5 million and $1.0 million for the three and nine months ended September 30, 2024, respectively, and $0.7 million and $2.1 million for the three and nine months ended September 30, 2023, respectively, was recorded to other expense.
16. STOCKHOLDERS’ EQUITY
On April 22, 2024, the Company issued an aggregate of 3,450,000 shares of common stock in an underwritten public offering, inclusive of the shares of common stock issued in connection with the underwriters exercise in full of their option to purchase additional shares of common stock. The Company sold the shares to the underwriters at the public offering price of $37.15
per share, less underwriting discounts and commissions of $1.67175 per share, resulting in net proceeds to the Company after deducting underwriting discounts and commissions and estimated offering expenses payable by the Company of $121.8 million.
17. NET LOSS PER SHARE
Basic net loss per share is computed by dividing net loss attributable to common stockholders by the weighted average number of common shares outstanding during each period. The Convertible and Redeemable Series A-2 Preferred Stock is considered a participating security during the applicable period. Net losses are not allocated to the Convertible and Redeemable Series A-2 stockholders, as they were not contractually obligated to share in the Company’s losses.
Diluted net loss per share is computed by dividing net loss attributable to common stockholders by the weighted average number of common and dilutive common equivalent shares outstanding for the period using the treasury-stock method or the as-converted method. Potentially dilutive shares are comprised of awards of restricted stock ("RSAs"), restricted stock units ("RSUs"), stock appreciation rights ("SARs") and shares of common stock underlying stock options outstanding under the Company's stock incentive plans. During the three and nine months ended September 30, 2024 and September 30, 2023, there is no difference in the number of shares used to calculate basic and diluted shares outstanding during the applicable period due to the Company’s net loss attributable to common stockholders and potentially dilutive shares being anti-dilutive.
The following table summarizes the computation of basic and diluted net loss per share attributable to common stockholders of the Company:
| | | | | | | | | | | | | | | | |
| | Three Months Ended September 30, | | | Nine Months Ended September 30, | |
| | 2024 | | | 2023 | | | 2024 | | | 2023 | |
Net loss | | $ | (10,564 | ) | | $ | (7,525 | ) | | $ | (34,091 | ) | | $ | (29,418 | ) |
Convertible and Redeemable Series A-2 Preferred Stock dividend | | | (2,750 | ) | | | (4,100 | ) | | | (8,314 | ) | | | (12,300 | ) |
Net loss attributable to common stockholders – basic and diluted | | | (13,314 | ) | | | (11,625 | ) | | | (42,405 | ) | | | (41,718 | ) |
Weighted-average number of shares of common stock outstanding – basic and diluted | | | 34,242 | | | | 30,143 | | | | 32,647 | | | | 30,016 | |
Net loss per share attributable to common stockholders – basic and diluted | | $ | (0.39 | ) | | $ | (0.39 | ) | | $ | (1.30 | ) | | $ | (1.39 | ) |
The following common stock equivalents were excluded from the calculation of diluted net loss per share attributable to common stockholders because their effect would have been anti-dilutive:
| | | | | | | | |
| | September 30, | |
| | 2024(1) | | | 2023(1) | |
Stock options | | | 3,059,061 | | | | 3,348,678 | |
Restricted stock | | | 2,629,026 | | | | 2,410,363 | |
Series A-2 Preferred Stock | | | 4,448,404 | | | | 5,447,090 | |
SARs | | | 3,000,000 | | | | 3,000,000 | |
_____________________________
(1) Includes 7,891,144 and 7,581,261 common stock equivalents that are out of the money as of September 30, 2024 and September 30, 2023, respectively.
18. STOCK-BASED PLANS AND COMPENSATION
Employee Equity Incentive Plans
The Company has two plans under which stock-based awards have been issued: (i) the Montrose Amended & Restated 2017 Stock Incentive Plan (“2017 Plan”) and (ii) the Montrose Amended & Restated 2013 Stock Option Plan (“2013 Plan”) (collectively the “Plans”).
The following number of shares were authorized to be issued and available for grant:
| | | | | | | | | | | |
| September 30, 2024 | |
| 2017 Plan | | | 2013 Plan | | | Total | |
Shares authorized to be issued | | 7,538,276 | | | | 2,036,219 | | | | 9,574,495 | |
Shares available for grant(1) | | 1,651,705 | | | | — | | | | 1,651,705 | |
| | | | | | | | |
| September 30, 2023 | |
| 2017 Plan | | | 2013 Plan | | | Total | |
Shares authorized to be issued | | 6,330,713 | | | | 2,036,219 | | | | 8,366,932 | |
Shares available for grant(1) | | 703,380 | | | | — | | | | 703,380 | |
(1) In January 2024 and January 2023 the Board of Directors ratified the addition of 1,207,563 and 1,189,801 shares of common stock, respectively, to the number of shares available for issuance under the 2017 Plan pursuant to the annual increase provision of such plan. Unless the Board of Directors determines otherwise, additional annual increases will be effective on each January 1, through January 1, 2027. The 2017 Plan permits the company to settle awards, if and when vested, in cash at its discretion. Pursuant to the terms of the 2017 Plan, the number of shares authorized for issuance thereunder will only be reduced with respect to shares of common stock actually issued upon exercise or settlement of an award. Shares of common stock subject to awards that have been canceled, expired, forfeited or otherwise not issued under an award and shares of common stock subject to awards settled in cash do not count as shares of common stock issued under the 2017 Plan. Shares available for grant exclude awards of stock appreciation rights approved in December 2021 that are subject to vesting based on the achievement of certain market conditions, which have not yet been, and may not be, achieved. See footnote 1 to the table in Common Stock Reserved for Future Issuance below for additional information on stock appreciation rights.
There were no stock-based compensation expenses related to the 2013 Plan in the three and nine months ended September 30, 2024 and 2023. Total stock-based compensation expense related to the 2017 Plan was as follows:
| | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
| Three Months Ended September 30, | |
| 2024 | | | 2023 | |
| Options | | | RSUs | | | SARs | | | Total | | | Options | | | RSUs | | | SARs | | | Total | |
Cost of revenue | $ | 285 | | | $ | 1,057 | | | $ | — | | | $ | 1,342 | | | $ | 399 | | | $ | 409 | | | $ | — | | | $ | 808 | |
Selling, general and administrative expense | | 499 | | | | 7,607 | | | | 2,315 | | | | 10,421 | | | | 1,050 | | | | 7,311 | | | | 2,315 | | | | 10,676 | |
Total | $ | 784 | | | $ | 8,664 | | | $ | 2,315 | | | $ | 11,763 | | | $ | 1,449 | | | $ | 7,720 | | | $ | 2,315 | | | $ | 11,484 | |
| | | | | | | | | | | | | | | | | | | | | | | |
| Nine Months Ended September 30, | |
| 2024 | | | 2023 | |
| Options | | | RSUs | | | SARs | | | Total | | | Options | | | RSUs | | | SARs | | | Total | |
Cost of revenue | $ | 914 | | | $ | 2,539 | | | $ | — | | | $ | 3,453 | | | $ | 1,214 | | | $ | 1,195 | | | $ | — | | | $ | 2,409 | |
Selling, general and administrative expense | | 2,074 | | | | 22,443 | | | | 6,896 | | | | 31,413 | | | | 3,844 | | | | 22,486 | | | | 6,870 | | | | 33,200 | |
Total | $ | 2,988 | | | $ | 24,982 | | | $ | 6,896 | | | $ | 34,866 | | | $ | 5,058 | | | $ | 23,681 | | | $ | 6,870 | | | $ | 35,609 | |
As of September 30, 2024 and September 30, 2023, there was $99.4 million and $132.8 million, respectively, of total unrecognized stock-based compensation expense related to unvested options, restricted stock and SARs granted under the Plans. Such unrecognized expense is expected to be recognized over a weighted-average 2.3 year period.
Montrose Amended & Restated 2017 Stock Incentive Plan
Restricted Stock Awards and Restricted Stock Units
RSAs and RSUs activity was as follows:
| | | | | | | | | | | | | | | |
| Nine Months Ended September 30, | |
| 2024 | | | 2023 | |
| Shares | | | Weighted-Average Grant Date Fair Value | | | Shares | | | Weighted-Average Grant Date Fair Value | |
Beginning outstanding shares | | 2,468,722 | | | | | | | 1,777,715 | | | | |
Granted | | 354,060 | | | $ | 40.12 | | | | 731,666 | | | $ | 34.47 | |
Forfeited/ cancelled | | (43,115 | ) | | $ | 36.70 | | | | (8,902 | ) | | $ | 32.18 | |
Vested | | (150,641 | ) | | $ | 37.46 | | | | (90,116 | ) | | $ | 36.81 | |
Ending outstanding shares | | 2,629,026 | | | | | | | 2,410,363 | | | | |
| | | | | | | | | | | |
Stock Appreciation Rights
As of September 30, 2024, there were 3,000,000 units of SARs outstanding under the 2017 Plan. These SARs represent the right to receive, upon exercise, a payment equal to the excess of (a) the fair market value of one share of the Company’s common stock, over (b) an exercise price of $66.79, payable, at the Company’s election, in cash or shares of common stock. These SARs vest on the 5th anniversary of the date of grant based on achievement of performance hurdles over a five year period, subject to continued service on the vesting date. The performance hurdles are as follows:
| |
SARs Stock Price Performance Hurdle | Portion of SARs Subject to Performance Hurdle |
$133.58 | 1/3 |
$166.98 | 1/3 |
$200.37 | 1/3 |
The performance hurdles shall be deemed achieved if the average trading price per share of the Company’s common stock equals or exceeds the applicable stock price performance hurdle set forth above for the trading days falling in a consecutive 20-day period prior to the vesting date. None of the market conditions have been achieved as of September 30, 2024.
The SARs expire 10 years after the grant date. The fair value of these SARs at the grant date was $46.0 million. The weighted average remaining contract life of these SARs as of September 30, 2024 was 7.21 years.
Options
The following summarizes the options activity of the 2017 Plan:
| | | | | | | | | | | | | | | | | | | |
| Options to Purchase Common Stock | | | Weighted-Average Exercise Price per Share | | | Weighted Average Grant Date Fair Value per Share | | | Weighted Average Remaining Contract Life (in Years) | | | Aggregate Intrinsic Value of In-The-Money Options | |
Outstanding as of December 31, 2022 | | 2,579,566 | | | $ | 31.00 | | | $ | 15.00 | | | | 7.8 | | | $ | 37,295 | |
Granted | | 253,980 | | | | 32.41 | | | | 13.98 | | | | — | | | | — | |
Forfeited/ cancelled | | (119,330 | ) | | | 35.81 | | | | — | | | | — | | | | — | |
Expired | | (2,950 | ) | | | 28.72 | | | | — | | | | — | | | | — | |
Exercised | | (173,554 | ) | | | 24.21 | | | | — | | | | — | | | | 3,701 | |
Outstanding as of September 30, 2023 | | 2,537,712 | | | $ | 30.95 | | | $ | 15.92 | | | | 7.3 | | | $ | 10,427 | |
| | | | | | | | | | | | | | |
Outstanding as of December 31, 2023 | | 2,516,272 | | | $ | 30.92 | | | $ | 15.95 | | | | 7.0 | | | $ | 13,825 | |
Forfeited/ cancelled | | (71,915 | ) | | | 38.64 | | | | — | | | | — | | | | — | |
Expired | | (20,510 | ) | | | 45.57 | | | | — | | | | — | | | | — | |
Exercised | | (51,524 | ) | | | 26.21 | | | | — | | | | — | | | | 732 | |
Outstanding as of September 30, 2024 | | 2,372,323 | | | $ | 30.66 | | | $ | 16.30 | | | | 6.3 | | | $ | 7,517 | |
Exercisable as of September 30, 2024 | | 1,840,673 | | | $ | 28.71 | | | | | | | 5.9 | | | $ | 7,517 | |
The following weighted-average assumptions were used in the Black-Scholes option-pricing model calculation:
| | | |
| September 30, 2023 | |
Common stock value (per share) | $ | 32.41 | |
Expected volatility | | 33.55 | % |
Risk-free interest rate | | 3.77 | % |
Expected life (years) | | 7.00 | |
Forfeiture rate | None | |
Dividend rate | None | |
Montrose Amended & Restated 2013 Stock Option Plan
The following summarizes the activity of the 2013 Plan:
| | | | | | | | | | | | | | | | | | | |
| Options to Purchase Common Stock | | | Weighted-Average Exercise Price per Share | | | Weighted Average Grant Date Fair Value per Share | | | Weighted Average Remaining Contract Life (in Years) | | | Aggregate Intrinsic Value of In-The-Money Options | |
Outstanding as of December 31, 2022 | | 855,695 | | | $ | 6.00 | | | $ | 2.00 | | | | 3.3 | | | $ | 32,478 | |
Expired | | (800 | ) | | | 6.03 | | | | — | | | | — | | | | — | |
Exercised | | (43,929 | ) | | | 7.47 | | | | — | | | | — | | | | 1,557 | |
Outstanding as of September 30, 2023 | | 810,966 | | | $ | 6.38 | | | $ | 2.11 | | | | 2.6 | | | $ | 18,554 | |
| | | | | | | | | | | | | | |
Outstanding as of December 31, 2023 | | 792,191 | | | $ | 6.40 | | | $ | 2.16 | | | | 2.4 | | | $ | 20,380 | |
Exercised | | (105,453 | ) | | | 5.86 | | | | | | | | | | |
Outstanding as of September 30, 2024 | | 686,738 | | | $ | 6.49 | | | $ | 2.49 | | | | 1.8 | | | $ | 13,606 | |
Exercisable as of September 30, 2024 | | 686,738 | | | $ | 6.49 | | | | | | | 1.8 | | | $ | 13,606 | |
Common Stock Reserved for Future Issuances—The Company has reserved certain stock of its authorized but unissued common stock for possible future issuance in connection with the following:
| | | | | | | |
| September 30, | |
| 2024 | | | 2023 | |
Montrose 2013 Stock Incentive Plan | | 686,738 | | | | 810,966 | |
Montrose 2017 Stock Incentive Plan(1) | | 9,653,054 | | | | 8,651,455 | |
| | 10,339,792 | | | | 9,462,421 | |
(1) In January 2024 and 2023, the Board of Directors ratified the addition of 1,207,563 and 1,189,801 shares of common stock, respectively, to the number of shares available for issuance under the 2017 Plan pursuant to the annual increase provision of such plan. Unless the Board of Directors determines otherwise, additional annual increases will be effective on each January 1, through January 1, 2027. The 2017 Plan permits the company to settle awards, if and when vested, in cash at its discretion. Pursuant to the terms of the 2017 Plan, the number of shares authorized for issuance thereunder will only be reduced with respect to shares of common stock actually issued upon exercise or settlement of an award. Shares of common stock subject to awards that have been canceled, expired, forfeited or otherwise not issued under an award and shares of common stock subject to awards settled in cash do not count as shares of common stock issued under the 2017 Plan. The Company expects to have sufficient shares available under the 2017 Plan to satisfy the future settlement of outstanding awards. Shares reserved for future issuance include 3,000,000 shares underlying the 3,000,000 performance SARs granted in December 2021 that are subject to vesting based on the achievement of certain market conditions. Assuming achievement at the highest price performance hurdle, approximately 2,000,000 shares of common stock would be issued upon vesting of these performance SARs. To date, none of the market conditions have been achieved.
19. SEGMENT INFORMATION
The Company has three operating and reportable segments: Assessment, Permitting and Response, Measurement and Analysis and Remediation and Reuse. These segments are monitored separately by management for performance against budget and prior year and are consistent with internal financial reporting. The Company’s operating segments are organized based upon primary services provided, the nature of the production process, types of customers, methods used to distribute the products and the nature of the regulatory environment.
Our Chief Executive Officer, who serves as the Chief Operating Decision Maker ("CODM"), reviews Segment Adjusted EBITDA as the primary measure of operating performance for all three operating segments. Segment Adjusted EBITDA is the calculated Company’s Earnings before Interest, Tax, Depreciation and Amortization (“EBITDA”), adjusted to exclude certain transactions such as stock-based compensation, acquisition costs and fair value changes in financial instruments, amongst others. Beginning in the first quarter of 2023, the calculation of Segment adjusted EBITDA no longer adjusts for start-up losses and investment in new services as the CODM no longer reviews the Segment Adjusted EBITDA measure without these costs. The CODM does not review segment assets as a measure of segment performance.
During the first quarter of 2023, the Company determined to discontinue one of its non-core specialty service lines within the lab testing business (the "Discontinued Specialty Lab"). On December 29, 2023, the Company sold the assets of the Discontinued Specialty Lab for a total sales price of $4.8 million, of which $0.5 million was received in cash and $4.3 million was issued as a promissory note receivable. The promissory note receivable is subject to an annual 9.0% interest rate and will be repaid in 60 monthly installments with the remaining balance payable in full on December 29, 2028. The promissory note receivable balance, net of expected loss and payment, was $2.1 million as of September 30, 2024 and December 31, 2023, respectively. The discontinuation of this specialty service line, which was part of the Company's Measurement and Analysis segment, did not represent a strategic shift that had a major effect on the Company’s operations and financial results, therefore it did not meet the requirements to be classified as discontinued operations.
Corporate and Other includes costs associated with general corporate overhead (including executive, legal, finance, safety, human resources, marketing and IT related costs) that are not directly related to supporting operations. Overhead costs that are directly related to supporting operations (such as insurance, software, licenses, shared services and payroll processing costs) are allocated to the operating segments on a basis that reasonably approximates an estimate of the use of these services.
Segment revenues and Adjusted EBITDA consisted of the following:
| | | | | | | | | | | | | | | | |
| | Three Months Ended September 30, | |
| | 2024 | | | 2023 | |
| | Segment Revenues | | | Segment Adjusted EBITDA | | | Segment Revenues | | | Segment Adjusted EBITDA | |
Assessment, Permitting and Response | | $ | 52,019 | | | $ | 11,188 | | | $ | 57,009 | | | $ | 14,878 | |
Measurement and Analysis | | | 58,583 | | | | 13,370 | | | | 50,468 | | | | 10,352 | |
Remediation and Reuse | | | 68,085 | | | | 11,655 | | | | 60,460 | | | | 7,446 | |
Total Operating Segments | | $ | 178,687 | | | $ | 36,213 | | | $ | 167,937 | | | $ | 32,676 | |
Corporate and Other | | | — | | | | (7,901 | ) | | | — | | | | (9,373 | ) |
Total | | $ | 178,687 | | | $ | 28,312 | | | $ | 167,937 | | | $ | 23,303 | |
| | | | | | | | | | | | |
| | Nine Months Ended September 30, | |
| | 2024 | 2023 | |
| | Segment Revenues | | | Segment Adjusted EBITDA | | | Segment Revenues | | | Segment Adjusted EBITDA | |
Assessment, Permitting and Response | | $ | 164,043 | | | $ | 40,088 | | | $ | 170,634 | | | $ | 42,977 | |
Measurement and Analysis | | | 158,889 | | | | 32,233 | | | | 143,050 | | | | 27,528 | |
Remediation and Reuse | | | 184,405 | | | | 25,594 | | | | 144,782 | | | | 18,767 | |
Total Operating Segments | | $ | 507,337 | | | $ | 97,915 | | | $ | 458,466 | | | $ | 89,272 | |
Corporate and Other | | | — | | | | (29,367 | ) | | | — | | | | (28,175 | ) |
Total | | $ | 507,337 | | | $ | 68,548 | | | $ | 458,466 | | | $ | 61,097 | |
Presented below is a reconciliation of the Company’s segment measure to net loss:
| | | | | | | | | | | | | | | | |
| | For the Three Months Ended September 30, | | | For the Nine Months Ended September 30, | |
| | 2024 | | | 2023 | | | 2024 | | | 2023 | |
Adjusted EBITDA | | $ | 28,312 | | | $ | 23,303 | | | $ | 68,548 | | | $ | 61,097 | |
Interest expense, net | | | (4,137 | ) | | | (2,089 | ) | | | (11,420 | ) | | | (5,507 | ) |
Income tax expense | | | (1,368 | ) | | | (1,324 | ) | | | (4,480 | ) | | | (2,842 | ) |
Depreciation and amortization | | | (13,240 | ) | | | (11,863 | ) | | | (37,408 | ) | | | (33,816 | ) |
Stock-based compensation | | | (11,763 | ) | | | (11,484 | ) | | | (34,866 | ) | | | (35,609 | ) |
Acquisition costs | | | (2,764 | ) | | | (1,499 | ) | | | (6,371 | ) | | | (4,970 | ) |
Fair value changes in financial instruments | | | (3,946 | ) | | | (806 | ) | | | (4,851 | ) | | | (1,814 | ) |
Fair value changes in business acquisition contingencies | | | (143 | ) | | | (459 | ) | | | (385 | ) | | | (414 | ) |
Expenses related to financing transactions | | | (41 | ) | | | (3 | ) | | | (280 | ) | | | (7 | ) |
Discontinued Specialty Lab(1) | | | (96 | ) | | | (1,302 | ) | | | (692 | ) | | | (5,321 | ) |
Other losses or expenses(2) | | | (1,378 | ) | | | 1 | | | | (1,886 | ) | | | (215 | ) |
Net loss | | $ | (10,564 | ) | | $ | (7,525 | ) | | $ | (34,091 | ) | | $ | (29,418 | ) |
__________________________
(1) Amounts consist of operating losses before depreciation related to the Discontinued Specialty Lab.
(2) The three and nine months ended September 30, 2024 consist primarily of non-recurring costs to centralize certain back-office functions. The nine months ended September 30, 2024 also includes costs associated with a lease abandonment.
The following table presents revenues by geographic location:
| | | | | | | | | | | | | | | | |
| | For the Three Months Ended September 30, | | | For the Nine Months Ended September 30, | |
| | 2024 | | | 2023 | | | 2024 | | | 2023 | |
United States | | $ | 139,574 | | | $ | 133,451 | | | $ | 405,428 | | | $ | 405,395 | |
Canada | | | 31,639 | | | | 31,206 | | | | 81,517 | | | | 44,488 | |
Other international | | | 7,473 | | | | 3,280 | | | | 20,391 | | | | 8,583 | |
Total revenue | | $ | 178,687 | | | $ | 167,937 | | | $ | 507,337 | | | $ | 458,466 | |
20. RELATED-PARTY TRANSACTIONS
The Company did not have any related party transactions during the three and nine months ended September 30, 2024 and September 30, 2023.
21. DEFINED CONTRIBUTION PLAN
On January 1, 2014, the Company established the Montrose Environmental Group 401(k) Savings Plan (the “401(k) Savings Plan”). As of September 30, 2024, and December 31, 2023, plan participants may defer up to 85.0% of their eligible wages for the year, up to the Internal Revenue Service dollar limit and catch-up contribution allowed by law. The Company provided employer matching contributions equal to 100.0% of the first 3.0% of the participant’s compensation and 50.0% of the participant’s elective deferrals that exceed 3.0% but do not exceed 5.0% of the participant’s compensation. Employer contributions under the 401(k) Savings Plan were $5.8 million and $17.4 million for the three and nine months ended September 30, 2024, respectively, and $2.0 million and $5.9 million for the three and nine months ended September 30, 2023, respectively, and are included within selling, general, and administrative expense on the unaudited condensed consolidated statements of operations.
FORWARD-LOOKING STATEMENTS
This Quarterly Report on Form 10-Q contains “forward-looking statements” within the meaning of Section 27A of the Securities Act of 1933, as amended, or the Securities Act, and Section 21E of the Securities Exchange Act of 1934, as amended, or the Exchange Act. These forward-looking statements relate to matters such as our industry, business strategy, goals and expectations concerning our market position, future operations, margins, profitability, capital expenditures, liquidity, capital resources and other financial and operating information. We use words such as “anticipate,” “assume,” “believe,” “contemplate,” “continue,” “could,” “estimate,” “expect,” “future,” “intend,” “may,” “plan,” “position,” “potential,” “predict,” “project,” “seek,” “should,” “target,” “will” and similar terms and phrases to identify forward-looking statements in this filing. All of our forward-looking statements are subject to risks and uncertainties that may cause actual results to differ materially from those that we are expecting, including:
•general global economic, business and other conditions, including inflationary and interest rate pressures, the cyclical nature of our industry and the significant fluctuations in events that impact our business;
•the parts of our business that depend on difficult to predict natural or manmade events and the fluctuations in our revenue and customer concentration as a result thereof;
•the highly competitive nature of our business;
•our ability to execute on our acquisition strategy and successfully integrate and realize benefits from our acquisitions;
•any failure in or breach of our networks and systems or other forms of cyber-attack;
•our ability to promote and develop our brands;
•our ability to maintain and expand our client base;
•our ability to maintain necessary accreditations and other authorizations in varying jurisdictions;
•significant environmental governmental regulation and liabilities;
•our ability to attract and retain qualified managerial and skilled technical personnel;
•allegations regarding compliance with professional standards, duties and statutory obligations and our ability to provide accurate results;
•the lack of formal long-term agreements with many of our clients;
•our ability to adapt to changing technology, industry standards or regulatory requirements, including emerging environmental, social and governance requirements;
•government clients and contracts;
•our ability to maintain our prices and manage costs;
•our ability to protect our intellectual property or claims that we infringe on the intellectual property rights of others;
•laws and regulations regarding handling of confidential information;
•our international operations;
•product related risks; and
•additional factors discussed in our filings with the Securities and Exchange Commission, or the SEC.
The forward-looking statements in this Quarterly Report on Form 10-Q are based on historical performance and management’s current plans, estimates and expectations in light of information currently available to us and are subject to uncertainty and changes in circumstances. There can be no assurance that future developments affecting us will be those that we have anticipated. Actual results or outcomes may differ materially from these expectations due to changes in global, regional or local political, economic, business, competitive, market, regulatory and other factors, many of which are beyond our control, as well as the other factors described in Item 1A. “Risk Factors” in our Annual Report on Form 10-K for the year ended December 31, 2023 filed with the SEC on February 29, 2024, or the 2023 Form 10-K.
Additional factors or events that could cause our actual results or outcomes to differ may also emerge from time to time, and it is not possible for us to predict all of them. In addition, historical, current and forward-looking sustainability-related statements may be based on standards for measuring progress that are still developing, internal controls and processes that continue to evolve, and assumptions that are subject to change in the future. Should one or more of these risks or uncertainties materialize, or should any of our assumptions prove to be incorrect, our actual results or outcomes may vary in material respects from what we may have expressed or implied by any forward-looking statement and, therefore, you
should not regard any forward-looking statement as a representation or warranty by us or any other person that we will successfully achieve the expectation, plan or objective expressed in such forward-looking statement in any specified time frame, or at all. We caution that you should not place undue reliance on any of our forward-looking statements. Any forward-looking statement made by us speaks only as of the date on which we make it. We undertake no obligation to publicly update any forward-looking statement, whether as a result of new information, future developments or otherwise, except as may be required by applicable securities laws.
Item 2. Management’s Discussion and Analysis of Financial Condition and Results of Operations.
The following discussion and analysis of our financial condition and results of operations should be read in conjunction with our historical audited and unaudited consolidated financial statements and related notes and other information included elsewhere in this filing and our other filings with the SEC, including our unaudited condensed consolidated financial statements and the accompanying notes as of and for the three and nine months ended September 30, 2024 and September 30, 2023 included in Part I, Item 1. “Financial Statements” in this Quarterly Report on Form 10-Q. This discussion contains forward-looking statements that involve risks and uncertainties. Our actual results could differ materially from such forward-looking statements. Factors that could cause or contribute to those differences include, but are not limited to, those identified below and those discussed in the section entitled “Forward-Looking Statements”, and elsewhere in this filing and our other filings with the SEC, including in Item 1A. Risk Factors in the 2023 Form 10-K.
Overview
Since our inception in 2012, our mission has been to help clients and communities meet their environmental goals and needs. According to data derived from a 2023 Environmental Industry Study prepared by Environmental Business International, Inc., or EBI, which we commissioned, the global environmental industry is estimated to be approximately $1.44 trillion, with $494.0 billion concentrated in the United States.
Our Segments
We provide environmental services to our clients through three business segments—Assessment, Permitting and Response, Measurement and Analysis and Remediation and Reuse. For more information on each of our operating segments, see Item 1. “Business” in the 2023 Form 10-K.
Assessment, Permitting and Response
Assessment, Permitting and Response segment provides scientific advisory and consulting services to support environmental assessments, environmental emergency response and recovery, toxicology consulting and environmental audits and permits for current operations, facility upgrades, new projects, decommissioning projects and development projects. We work closely with clients to navigate the regulatory process at the local, state, provincial and federal levels, identify the potential environmental and political impacts of their decisions and develop practical mitigation approaches, as needed. In addition to environmental toxicology, and given our expertise in helping businesses plan for and respond to disruptions, our scientists and response teams have helped clients navigate their preparation for and response to emergency response situations.
Measurement and Analysis
Measurement and Analysis segment is one of the largest providers of environmental testing and laboratory services in North America. Our highly credentialed teams test and analyze air, water and soil to determine concentrations of contaminants, as well as the toxicological impact of contaminants on flora, fauna and human health. Our offerings include source and ambient air testing and monitoring, leak detection, and advanced multi-media laboratory services, including air, soil, stormwater, wastewater and drinking water analysis.
Remediation and Reuse
Remediation and Reuse segment provides clients with engineering, design, and implementation services, primarily (i) treatment technologies which treat contaminated water or create biogas from waste, or (ii) soil remediation. Our employees, including engineers, scientists and consultants, provide these services to assist our clients in designing solutions, managing products and mitigating environmental risks and liabilities at their locations. We do not own the properties or facilities at which we implement these projects or the underlying liabilities, nor do we own material amounts of the equipment used in projects.
These operating segments have been structured and organized to align with how we view and manage the business with the full lifecycle of our clients’ targeted environmental concerns and needs in mind. Within each segment, we cover similar service offerings, regulatory frameworks, internal operating structures and client types. Corporate activities not directly related to segment performance, including general corporate expenses, interest and taxes, are reported separately.
Key Factors that Affect Our Business and Our Results
Our operating results and financial performance are influenced by a variety of internal and external trends and other factors. Some of the more important factors are discussed briefly below.
Acquisitions
We have been, and expect to continue to be, an acquisitive company. Acquisitions have expanded our environmental service capabilities across all three segments, our access to technology, as well as our geographic reach in the United States, Canada, Europe and Australia. The table below sets forth the number of acquisitions completed, revenues generated by and the percentage of total revenues attributable to those acquisitions completed during the three and nine months ended September 30, 2024 and September 30, 2023:
| | | | | | | | | | | | | | | | |
| | Three Months Ended September 30, | | | Nine Months Ended September 30, | |
(Revenues in thousands) | | 2024 | | | 2023 | | | 2024 | | | 2023 | |
Acquisitions completed | | | 2 | | | | 1 | | | | 6 | | | | 5 | |
Revenues attributable to acquisitions completed in the period | | $ | 4,304 | | (1) | $ | 305 | | (1) | $ | 26,600 | | | $ | 40,809 | |
Percentage of revenues | | | 2.4 | % | | | 0.2 | % | | | 5.2 | % | | | 8.9 | % |
_________________________________
(1)Acquisitions revenue amounts in Note 7 to our unaudited condensed consolidated financial statements included in Part I, Item 1. “Financial Statements” includes third quarter revenue from acquisitions completed in the nine months ended September 30, 2024 and 2023 of $15.0 million and $29.2 million, respectively, whereas this disclosure includes third quarter revenue only attributable to acquisitions acquired during the three months ended September 30, 2024 and 2023.
Revenues from acquired companies exclude intercompany revenues from revenue synergies realized between business lines within operating segments, as these are eliminated at the consolidated segment and Company level. We expect our revenue growth to continue to be driven in significant part by acquisitions. See Note 7 to our unaudited condensed consolidated financial statements included in Part I, Item 1. “Financial Statements.”
As a result of our acquisitions, goodwill and other intangible assets represent a significant proportion of our total assets, and amortization of intangible assets has historically been a significant expense. Our historical financial statements also include other acquisition-related costs, including costs relating to external legal support, diligence and valuation services and other transaction and integration-related matters. In addition, in any year gains and losses from changes in the fair value of business acquisition contingencies such as earn-outs could be significant. The amount of each for the three and nine months ended September 30, 2024 and September 30, 2023, was as follows:
| | | | | | | | | | | | | | | | |
| | Three Months Ended September 30, | | | Nine Months Ended September 30, | |
(in thousands) | | 2024 | | | 2023 | | | 2024 | | | 2023 | |
Amortization expense | | $ | 8,978 | | | $ | 7,922 | | | $ | 24,621 | | | $ | 22,512 | |
Acquisition-related costs | | | 2,764 | | | | 1,499 | | | | 6,370 | | | | 4,970 | |
Fair value changes in business acquisition contingencies | | | (143 | ) | | | 459 | | | | (385 | ) | | | 414 | |
We expect that amortization of identifiable intangible assets and other acquisition-related costs, assuming we continue to acquire, will continue to be significant.
Additionally, we made earn-out payments of $1.5 million in March 2024 in connection with our acquisition of Huco Consulting, Inc. ("Huco"), of which, $0.4 million was paid in cash, and the remaining $1.1 million in the Company's common stock. In connection with certain of our acquisitions, we may make up to $58.6 million in aggregate earn-out payments between the years 2024 and 2026, of which up to $23.4 million may be paid only in cash, up to $13.1 million may be paid only in common stock and up to $22.1 million may be paid, at our option, in cash or common stock. See Note 7 to our unaudited condensed consolidated financial statements included in Part I, Item 1. “Financial Statements.”
Organic Growth
We define organic growth as the change in revenues excluding revenues from (i) our environmental emergency response business, (ii) acquisitions for the first twelve months following the date of acquisition, and (iii) businesses held for sale, disposed of or discontinued. Management uses organic growth as one of the means by which it assesses our results of operations. Organic growth is not, however, a measure of revenue growth calculated in accordance with U.S. generally accepted accounting principles, or GAAP, and should be considered in conjunction with revenue growth calculated in accordance with GAAP. We have grown organically over the long term and expect to continue to do so.
Discontinued Service Lines and Contracts
Periodically, or when circumstances warrant, we evaluate the performance of our business services to ensure that performance and outlook are consistent with expectations, and that the services offered are consistent with the Company’s mission.
As part of this evaluation, during the first quarter of 2023, we determined to sell one of our specialty lab testing businesses, the Discontinued Specialty Lab, whose service offering was non-core to the Company’s business. On December 29, 2023, we sold the assets of the Discontinued Specialty Lab for a total sales price of $4.8 million. The discontinuation of this specialty service line did not represent a strategic shift that had a major effect on our operations and financial results, therefore it did not meet the requirements to be classified as discontinued operations.
Revenue Mix
Our segments and our business lines within each segment generate different levels of profitability and, accordingly, shifts in the mix of revenues between segments can impact our consolidated reported net income, net loss margin, Segment Adjusted EBITDA and Segment Adjusted EBITDA margin from quarter to quarter and year to year. Inter-company revenues between business lines within segments have been eliminated. See Note 19 to our unaudited condensed consolidated financial statements included in Part 1, Item 1 “Financial Statements.”
Our revenues and certain expenses, including selling, general and administrative expense, vary from period to period due primary to changes in organic growth, the incremental contribution from recent acquisitions and strategic decisions we may make from time to time. When we refer to changes driven by organic growth, we are referring to the contribution from businesses that have been part of Montrose for more than 12 months, with certain limited exclusions as discussed in greater detail above. In a given reporting period, when we refer to revenue changes driven by acquisitions, we are referring to the revenue contribution from any acquisition from its closing date through the first 12 months of that acquisition, at which point any subsequent contribution therefrom would be organic.
Financing Costs
Total debt at September 30, 2024 was $249.8 million net of deferred debt issuance costs, which was an increase of $86.6 million compared to December 31, 2023. The increase is primarily driven by the additional $50.0 million term loan and additional usage of our revolving line of credit, partially offset by repayments and amortization of the various debt noted.
Interest expense, net was $4.1 million and $11.4 million in the three and nine months ended September 30, 2024, respectively, and $2.1 million and $5.5 million in the three and nine months ended September 30, 2023, respectively. We expect interest expense to remain a significant cost as we continue to leverage our credit facility to support our operations and future acquisitions.
See Note 12 to our unaudited condensed consolidated financial statements included in Part 1, Item 1 “Financial Statements” and “Liquidity and Capital Resources.”
Corporate and Operational Infrastructure Investments
Our historical operating results reflect the impact of our ongoing investments in our corporate infrastructure to support our growth. We have made and expect to continue to make investments in our business platform that we believe have laid the foundation for continued growth. Investments in logistics, quality, risk management, sales and marketing, safety, human resources, research and development, finance and information technology and other areas enable us to support continued growth. These investments should allow us to improve our margins over time.
Seasonality
Due to the field-based nature of certain of our services, weather patterns generally impact our field-based teams’ ability to operate in the winter months. As a result, our operating results could experience some quarterly variability with generally lower revenues and lower earnings in the first and fourth quarters and higher overall revenues and earnings in the second and third quarters. As we continue to grow and expand into new geographies and service lines, quarterly variability in our Measurement and Analysis and Remediation and Reuse segments may deviate from historical trends.
Earnings Volatility
In addition to the impact of seasonality on earnings, our emergency response business exposes us to potentially significant revenue and earnings fluctuations tied both to the timing of large environmental emergency response projects following an incident or natural disaster or more broad scale events such as the COVID-19 pandemic. We also saw significant emergency response revenue in 2023 from a single event. Demand for environmental emergency response services remains difficult to predict and as a result, we may have experienced revenues and earnings in prior years that are not indicative of future results, making those periods particularly difficult comparisons for future periods. Earnings volatility is also driven by the timing of large projects, particularly in our Remediation and Reuse segment, and the impact of acquisitions. As a result of these factors, and because demand for environmental services is not driven by specific or predictable patterns in one or more fiscal quarters, our business is better assessed based on yearly results.
Results of Operations
The Three And Nine Months Ended September 30, 2024 Compared to the Three And Nine Months Ended September 30, 2023
| | | | | | | | | | | | | | | | |
| | Three Months Ended September 30, | | | Nine Months Ended September 30, | |
(in thousands, except per share data) | | 2024 | | | 2023 | | | 2024 | | | 2023 | |
Revenues | | $ | 178,687 | | | $ | 167,937 | | | $ | 507,337 | | | $ | 458,466 | |
Cost of revenues (exclusive of depreciation and amortization) | | | 105,596 | | | | 102,155 | | | | 306,239 | | | | 281,984 | |
Selling, general and administrative expense | | | 60,869 | | | | 56,901 | | | | 177,182 | | | | 161,761 | |
Fair value changes in business acquisition contingencies | | | 143 | | | | 459 | | | | 385 | | | | 414 | |
Depreciation and amortization | | | 13,240 | | | | 11,863 | | | | 37,408 | | | | 33,816 | |
Loss from operations | | | (1,161 | ) | | | (3,441 | ) | | | (13,877 | ) | | | (19,509 | ) |
Other income (expense), net | | | (3,898 | ) | | | (671 | ) | | | (4,314 | ) | | | (1,560 | ) |
Interest expense, net | | | (4,137 | ) | | | (2,089 | ) | | | (11,420 | ) | | | (5,507 | ) |
Loss before income taxes | | | (9,196 | ) | | | (6,201 | ) | | | (29,611 | ) | | | (26,576 | ) |
Income tax expense | | | 1,368 | | | | 1,324 | | | | 4,480 | | | | 2,842 | |
Net loss | | | (10,564 | ) | | | (7,525 | ) | | | (34,091 | ) | | | (29,418 | ) |
Series A-2 dividend payment | | | (2,750 | ) | | | (4,100 | ) | | | (8,314 | ) | | | (12,300 | ) |
Net loss attributable to common stockholders | | $ | (13,314 | ) | | $ | (11,625 | ) | | $ | (42,405 | ) | | $ | (41,718 | ) |
Weighted average number of shares — basic and diluted | | | 34,242 | | | | 30,143 | | | | 32,647 | | | | 30,016 | |
Loss per share — basic and diluted | | $ | (0.39 | ) | | $ | (0.39 | ) | | $ | (1.30 | ) | | $ | (1.39 | ) |
Revenues
| | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
| | Three Months Ended September 30, | | | Change | | | Nine Months Ended September 30, | | | Change | |
(in thousands, except %) | | 2024 | | | 2023 | | | $ | | | % | | | 2024 | | | 2023 | | | $ | | | % | |
Revenues | | $ | 178,687 | | | $ | 167,937 | | | $ | 10,750 | | | | 6.4 | % | | $ | 507,337 | | | $ | 458,466 | | | $ | 48,871 | | | | 10.7 | % |
Revenue for the three months ended September 30, 2024 increased $10.8 million or 6.4% as compared to the three months ended September 30, 2023. The increase was primarily driven by acquisitions, which contributed $15.4 million to the increase in revenues, and strong organic growth driven primarily by our Assessment, Permitting and Response and Measurement and Analysis segments. These increases were partially offset by $12.8 million lower environmental emergency response service revenues, lower treatment technology revenue within our Remediation and Reuse segment, and prior year revenues from the Discontinued Specialty Lab of $2.0 million, which was sold in December 2023.
Revenue for the nine months ended September 30, 2024 increased $48.9 million or 10.7% as compared to the nine months ended September 30, 2023. The increase was primarily driven by acquisitions, which contributed $63.6 million to the increase in revenues, and strong organic growth driven by our Assessment, Permitting and Response and Measurement and Analysis segments. These increases were partially offset by $34.9 million lower environmental emergency response service revenues, lower treatment technology revenue within our Remediation and Reuse segment, and prior year revenues from the Discontinued Specialty Lab of $6.1 million.
See “—Segment Results of Operations” below for revenue by segment analysis.
Cost of Revenues
| | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
| | Three Months Ended September 30, | | | Change | | | Nine Months Ended September 30, | | | Change | |
(in thousands, except %) | | 2024 | | | 2023 | | | $ | | | % | | | 2024 | | | 2023 | | | $ | | | % | |
Cost of revenues (exclusive of depreciation and amortization) | | $ | 105,596 | | | $ | 102,155 | | | $ | 3,441 | | | | 3.4 | % | | $ | 306,239 | | | $ | 281,984 | | | $ | 24,255 | | | | 8.6 | % |
Cost of revenues consists of all direct costs required to provide services, including fixed and variable direct labor costs, equipment purchases and rental, and other outside services, field and lab supplies, vehicle costs and travel-related expenses. Variable costs of revenues generally follow the same trends as revenue, while fixed costs tend to change primarily as a result of acquisitions.
Cost of revenues for the three months ended September 30, 2024 compared to the three months ended September 30, 2023 increased by $3.4 million driven primarily by a $7.3 million increase in direct labor costs and a $3.5 million increase in other cost of revenues, partially offset by a $5.7 million decrease in field supplies and equipment costs. Cost of revenues as a percentage of revenue for the three months ended September 30, 2024 was 59.1%, compared to 60.8% for the three months ended September 30, 2023. This percentage decrease was driven primarily by revenue mix.
Cost of revenues for the nine months ended September 30, 2024 compared to the nine months ended September 30, 2023 increased by $24.3 million driven primarily by a $26.8 million increase in direct labor costs, a $3.4 million increase in outside services costs, and a $6.1 million increase in other cost of revenues, partially offset by a $14.0 million decrease in field supplies and equipment costs. Cost of revenues as a percentage of revenue for the nine months ended September 30, 2024 was 60.4%, compared to 61.5% for the nine months ended September 30, 2023. This percentage decrease was driven primarily by revenue mix.
Selling, General and Administrative Expense
| | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
| | Three Months Ended September 30, | | | Change | | | Nine Months Ended September 30, | | | Change | |
(in thousands, except %) | | 2024 | | | 2023 | | | $ | | | % | | | 2024 | | | 2023 | | | $ | | | % | |
Selling, general and administrative expense | | $ | 60,869 | | | $ | 56,901 | | | $ | 3,968 | | | | 7.0 | % | | $ | 177,182 | | | $ | 161,761 | | | $ | 15,421 | | | | 9.5 | % |
Selling, general and administrative expense consists of general corporate overhead, including executive, legal, finance, safety, risk management, human resource, marketing and information technology related costs, as well as indirect operational costs of labor, rent, insurance and stock-based compensation.
Selling, general and administrative expense for the three months ended September 30, 2024 compared to the three months ended September 30, 2023 increased $4.0 million or 7.0% primarily due to the impact of acquisitions, which added $2.9 million to selling, general and administrative expense, and an increase in IT, travel and bad debt expenses, partially offset by lower labor and facilities cost.
Selling, general and administrative expense for the nine months ended September 30, 2024 compared to the nine months ended September 30, 2023 increased $15.4 million or 9.5% primarily due to the impact of acquisitions, which added $9.2 million to selling, general and administrative expense, as well as an increase in acquisition-related costs, facilities cost, and an increase in IT and travel expenses.
See Part I, Item 3. “Quantitative and Qualitative Disclosures About Market Risk” for additional information regarding the impact of inflation on our business.
Depreciation and Amortization
| | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
| | Three Months Ended September 30, | | | Change | | | Nine Months Ended September 30, | | | Change | |
(in thousands, except %) | | 2024 | | | 2023 | | | $ | | | % | | | 2024 | | | 2023 | | | $ | | | % | |
Depreciation and amortization | | $ | 13,240 | | | $ | 11,863 | | | $ | 1,377 | | | | 11.6 | % | | $ | 37,408 | | | $ | 33,816 | | | $ | 3,592 | | | | 10.6 | % |
The increase in depreciation of property and equipment and the amortization of intangible assets and finance leases were primarily driven by an increase of $2.1 million in amortization of intangible assets during both the three and nine months ended September 30, 2024 compared to the prior year periods. See Note 8 to our unaudited condensed consolidated financial statements included in Part 1, Item 1. “Financial Statements.”
Other Income (Expense), Net
| | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
| | Three Months Ended September 30, | | | Change | | | Nine Months Ended September 30, | | | Change | |
(in thousands, except %) | | 2024 | | | 2023 | | | $ | | | % | | | 2024 | | | 2023 | | | $ | | | % | |
Other income (expense), net | | $ | (3,898 | ) | | $ | (671 | ) | | $ | (3,227 | ) | | | 481 | % | | $ | (4,314 | ) | | $ | (1,560 | ) | | $ | (2,754 | ) | | | 177 | % |
Other income (expense), net for the three months ended September 30, 2024 was comprised of losses of $3.5 million related to a fair value adjustment on our interest rate swaps and a $0.5 million charge related to a fair value adjustment on the Series A-2 Preferred Stock conversion option, partially offset by $0.8 million of other income. Other income (expense), net for the three months ended September 30, 2023 was comprised of a $0.7 million charge related to a fair value adjustment on our interest rate swaps, as well as a loss of $0.1 million related to a fair value adjustment on the Series A-2 Preferred Stock conversion option.
Other income (expense), net for the nine months ended September 30, 2024 was comprised of losses of $3.8 million related to a fair value adjustment on our interest rate swaps and a $1.0 million charge related to a fair value adjustment on the Series A-2 Preferred Stock conversion option, partially offset by $0.5 million of other income. Other income (expense), net for the nine months ended September 30, 2023 was comprised primarily of a $2.1 million charge related to a fair value adjustment on the Series A-2 Preferred Stock conversion option.
See Notes 13 and 15 to our unaudited condensed consolidated financial statements included in Part 1, Item 1. “Financial Statements.”
Interest Expense, Net
| | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
| | Three Months Ended September 30, | | | Change | | | Nine Months Ended September 30, | | | Change | |
(in thousands, except %) | | 2024 | | | 2023 | | | $ | | | % | | | 2024 | | | 2023 | | | $ | | | % | |
Interest expense, net | | $ | (4,137 | ) | | $ | (2,089 | ) | | $ | (2,048 | ) | | | 98.1 | % | | $ | (11,420 | ) | | $ | (5,507 | ) | | $ | (5,913 | ) | | | 107.4 | % |
Interest expense, net for the three and nine months ended September 30, 2024 and 2023 increased primarily as a result of higher interest rates and higher debt balance.
Weighted average interest rates as of September 30, 2024 and September 30, 2023 were 7.2% and 6.6%%, respectively. See “—Key Factors that Affect Our Business and Our Results—Financing Costs” and Notes 12 and 13 to our unaudited condensed consolidated financial statements included in Part I, Item 1. “Financial Statements.”
Income Tax Expense
| | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
| | Three Months Ended September 30, | | | Change | | | Nine Months Ended September 30, | | | Change | |
(in thousands, except %) | | 2024 | | | 2023 | | | $ | | | % | | | 2024 | | | 2023 | | | $ | | | % | |
Income tax expense | | $ | 1,368 | | | $ | 1,324 | | | $ | 44 | | | | 3.3 | % | | $ | 4,480 | | | $ | 2,842 | | | $ | 1,638 | | | | 57.6 | % |
The income tax expense for the three and nine months ended September 30, 2024 increased compared to the three and nine months ended September 30, 2023 primarily as a result of certain tax inclusions from foreign acquisitions in 2024 in addition to an increase in deductible goodwill amortization associated with recent U.S. acquisitions. The income tax expense is primarily related to operations in the United States, Canada and Australia.
Segment Results of Operations
The Three And Nine Months Ended September 30, 2024 Compared to the Three And Nine Months Ended September 30, 2023
| | | | | | | | | | | | | | | | | | | | | | | | |
| | Three Months Ended September 30, | |
| | 2024 | | | 2023 | |
(in thousands, except %) | | Segment Revenues | | | Segment Adjusted EBITDA(1) | | | Segment Adjusted EBITDA Margin(2) | | | Segment Revenues | | | Segment Adjusted EBITDA(1) | | | Segment Adjusted EBITDA Margin(2) | |
Assessment, Permitting and Response | | $ | 52,019 | | | $ | 11,188 | | | | 21.5 | % | | $ | 57,009 | | | $ | 14,878 | | | | 26.1 | % |
Measurement and Analysis | | | 58,583 | | | | 13,370 | | | | 22.8 | | | | 50,468 | | | | 10,352 | | | | 20.5 | |
Remediation and Reuse | | | 68,085 | | | | 11,655 | | | | 17.1 | | | | 60,460 | | | | 7,446 | | | | 12.3 | |
Total Operating Segments | | $ | 178,687 | | | $ | 36,213 | | | | 20.3 | % | | $ | 167,937 | | | $ | 32,676 | | | | 19.5 | % |
Corporate and Other | | $ | — | | | $ | (7,901 | ) | | | (4.4 | )% | | $ | — | | | $ | (9,373 | ) | | | (5.6 | )% |
| | | | | | | | | | | | | | | | | | |
| | Nine Months Ended September 30, | |
| | 2024 | | | 2023 | |
| | Segment Revenues | | | Segment Adjusted EBITDA(1) | | | Segment Adjusted EBITDA Margin(2) | | | Segment Revenues | | | Segment Adjusted EBITDA(1) | | | Segment Adjusted EBITDA Margin(2) | |
Assessment, Permitting and Response | | $ | 164,043 | | | $ | 40,088 | | | | 24.4 | % | | $ | 170,634 | | | $ | 42,977 | | | | 25.2 | % |
Measurement and Analysis | | | 158,889 | | | | 32,233 | | | | 20.3 | | | | 143,050 | | | | 27,528 | | | | 19.2 | |
Remediation and Reuse | | | 184,405 | | | | 25,594 | | | | 13.9 | | | | 144,782 | | | | 18,767 | | | | 13.0 | |
Total Operating Segments | | $ | 507,337 | | | $ | 97,915 | | | | 19.3 | % | | $ | 458,466 | | | $ | 89,272 | | | | 19.5 | % |
Corporate and Other | | $ | — | | | $ | (29,367 | ) | | | (5.8 | )% | | $ | — | | | $ | (28,175 | ) | | | (6.1 | )% |
(1)For purposes of evaluating segment profit, the Company’s chief operating decision maker reviews Segment Adjusted EBITDA as a basis for making the decisions to allocate resources and assess performance. See Note 19 to our unaudited condensed consolidated financial statements included in Part I, Item 1. “Financial Statements.”
(2)Represents Segment Adjusted EBITDA as a percentage of segment revenues.
Revenues
| | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
| | Three Months Ended September 30, | | | Change | | | Nine Months Ended September 30, | | | Change | |
(in thousands, except %) | | 2024 | | | 2023 | | | $ | | | % | | | 2024 | | | 2023 | | | $ | | | % | |
Assessment, Permitting and Response | | $ | 52,019 | | | $ | 57,009 | | | $ | (4,990 | ) | | | (8.8 | )% | | $ | 164,043 | | | $ | 170,634 | | | $ | (6,591 | ) | | | (3.9 | )% |
Measurement and Analysis | | | 58,583 | | | | 50,468 | | | | 8,115 | | | | 16.1 | | | | 158,889 | | | | 143,050 | | | | 15,839 | | | | 11.1 | |
Remediation and Reuse | | | 68,085 | | | | 60,460 | | | | 7,625 | | | | 12.6 | | | | 184,405 | | | | 144,782 | | | | 39,623 | | | | 27.4 | |
Total Operating Segments | | $ | 178,687 | | | $ | 167,937 | | | $ | 10,750 | | | | 6.4 | % | | $ | 507,337 | | | $ | 458,466 | | | $ | 48,871 | | | | 10.7 | % |
Assessment, Permitting and Response segment revenues for the three and nine months ended September 30, 2024 decreased compared to the three and nine months ended September 30, 2023 due to a decline in revenues from environmental emergency responses of $12.8 million and $34.9 million, respectively, partially offset by strong organic growth of $5.1 million and $25.6 million, respectively, mainly within our consulting and advisory services, and the impact of acquisitions, which contributed $2.7 million to the increase in both the three and nine months ended September 30, 2024 .
Measurement and Analysis segment revenues for the three and nine months ended September 30, 2024 increased compared to the three and nine months ended September 30, 2023 as a result of strong organic growth of $8.5 million and $19.0 million, respectively, the impact of acquisitions, which contributed $1.6 million and $2.9 million, respectively, partially offset by the sale of the Discontinued Specialty Lab in December 2023, which contributed $2.0 million and $6.1 million to revenues in the respective prior year periods.
Remediation and Reuse segment revenues for the three and nine months ended September 30, 2024 increased compared to the three and nine months ended September 30, 2023, primarily driven by acquisitions. Specifically, acquisitions contributed $11.1 million and $57.9 million to the increase in revenues in the three and nine months ended September 30, 2024, respectively. These increases were partially offset by certain treatment technology project start dates that shifted beyond the second half of 2024.
Segment Adjusted EBITDA
| | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
| | Three Months Ended September 30, | | | Change | | | Nine Months Ended September 30, | | | Change | |
(in thousands, except %) | | 2024 | | | 2023 | | | $ | | | Margin % | | | 2024 | | | 2023 | | | $ | | | Margin % | |
Assessment, Permitting and Response | | $ | 11,188 | | | $ | 14,878 | | | $ | (3,690 | ) | | | (4.6 | )% | | $ | 40,088 | | | $ | 42,977 | | | $ | (2,889 | ) | | | (0.7 | )% |
Measurement and Analysis | | | 13,370 | | | | 10,352 | | | | 3,018 | | | | 2.3 | | | | 32,233 | | | | 27,528 | | | | 4,705 | | | | 1.0 | |
Remediation and Reuse | | | 11,655 | | | | 7,446 | | | | 4,209 | | | | 4.8 | | | | 25,594 | | | | 18,767 | | | | 6,827 | | | | 0.9 | |
Total Operating Segments | | $ | 36,213 | | | $ | 32,676 | | | $ | 3,537 | | | | 0.8 | % | | $ | 97,915 | | | $ | 89,272 | | | $ | 8,643 | | | | (0.2 | )% |
Corporate and Other | | $ | (7,901 | ) | | $ | (9,373 | ) | | $ | 1,472 | | | | | | $ | (29,367 | ) | | $ | (28,175 | ) | | $ | (1,192 | ) | | | |
Assessment, Permitting and Response Segment Adjusted EBITDA and Segment Adjusted EBITDA margin for the three and nine months ended September 30, 2024 decreased compared to the three and nine months ended September 30, 2023 primarily due to a reduction in higher margin emergency response revenues.
Measurement and Analysis Segment Adjusted EBITDA and Segment Adjusted EBITDA margin for the three and nine months ended September 30, 2024 increased compared the three and nine months ended September 30, 2023 primarily due to the operating leverage driven by higher revenue growth.
Remediation and Reuse Segment Adjusted EBITDA for the three and nine months ended September 30, 2024 increased compared the three and nine months ended September 30, 2023 due to higher revenues. Improved Segment Adjusted EBITDA margin in the three months ended September 30, 2024 was driven primarily by acquisitions and improved Matrix margins. Improved segment Adjusted EBITDA margin in the nine months ended September 30, 2024 was driven primarily by acquisitions.
Corporate and other costs for the three months ended September 30, 2024 decreased $1.5 million primarily due to lower payroll related costs of $0.5 million and the timing of various other expenses including audit and other marketing related costs. Corporate and other costs for the nine months ended September 30, 2024 increased $1.2 million primarily due to higher travel and IT costs as well as an increase in professional fees. Corporate costs as a percentage of revenues were lower in both the three and nine months ended September 30, 2024.
Liquidity and Capital Resources
Liquidity describes the ability of a company to generate sufficient cash flows to meet the cash requirements of its business operations, including working capital needs, debt service, acquisitions, other commitments and contractual obligations. We consider liquidity in terms of cash flows from operations and other sources, including availability under our credit facility, and their sufficiency to fund our operating and investing activities.
Our principal sources of liquidity have been borrowings under our credit facilities, other borrowing arrangements, proceeds from the issuance of common and preferred stock and cash generated by operating activities. Historically, we have financed our operations and acquisitions from a combination of cash generated from operations, periodic borrowings under senior secured credit facilities, and proceeds from the issuance of common and preferred stock. Our primary cash needs are for day to day operations, to fund working capital requirements, to fund our acquisition strategy and any related cash earn-out obligations, to pay interest and principal on our indebtedness and dividends on our Series A-2 Preferred Stock, and to make capital expenditures. Additionally, in connection with certain acquisitions, we agree to earn-out provisions and other purchase price adjustments that may require future payments. We may make up to $58.6 million in aggregate earn-out payments between the years 2024 and 2026 in connection with the acquisitions of Sensible, Vandrensning, EPIC, 2DOT, Spirit and Origins, of which up to $23.4 million may be paid only in cash, up to $13.1 million may be paid only in common stock and up to $22.1 million may be paid in cash or, at our option, in common stock. See Note 7 to our unaudited condensed consolidated financial statements included in Part 1, Item 1. “Financial Statements.”
We expect to continue to fund our liquidity requirements, including any cash earn-out payments that may be required in connection with acquisitions, through cash generated from operations and borrowings under our credit facility. We believe these sources will be sufficient to fund our cash needs for the short- and long-term.
Cash Flows
The following table summarizes our cash flows for the periods presented:
| | | | | | | | |
| | Nine Months Ended September 30, | |
(in thousands) | | 2024 | | | 2023 | |
Net cash provided by (used in): | | | | | | |
Operating activities | | $ | (9,721 | ) | | $ | 41,472 | |
Investing activities | | | (137,190 | ) | | | (96,982 | ) |
Financing activities | | | 136,583 | | | | (10,869 | ) |
Change in cash, cash equivalents and restricted cash | | $ | (10,328 | ) | | $ | (66,379 | ) |
Operating Activities
Cash flows from operating activities can fluctuate from period-to-period as earnings, working capital needs and the timing of payments for contingent consideration, taxes, bonus payments and other operating items impact reported cash flows.
For the nine months ended September 30, 2024, net cash used in operating activities was $9.7 million compared to net cash provided by operating activities of $41.5 million for the nine months ended September 30, 2023. The period-over-period decrease of $51.2 million was primarily due to an increase in accounts receivable and contract assets of $45.9 million driven by higher revenues, the previously disclosed temporary invoicing delays associated with the integration of Matrix, which is substantially addressed and collections are returning to a normal cadence, and slow payments on a single large US government funded project, which are expected to be resolved by year end. The year over year change was also impacted by a decrease in accrued payroll and benefits of $4.9 million following larger bonus payments made in March 2024 than in the prior year.
Investing Activities
For the nine months ended September 30, 2024, net cash used in investing activities was $137.2 million, driven by cash paid for the acquisitions of EPIC, 2DOT, ETA, Paragon, Spirit, and Origins, net of cash acquired, of $113.0 million, $19.1 million in purchases of property and equipment, $3.4 million in payment of other purchase price obligations, and $2.1 million in proprietary software development costs.
For the nine months ended September 30, 2023, net cash used in investing activities was $97.0 million, driven by cash paid for the acquisitions of Matrix, GreenPath, Vandrensning, Frontier and EAI, net of cash acquired, of $66.2 million, $25.0 million in cash consideration for purchases of property and equipment (which included the purchase of a $12.2 million replacement aircraft for use in emergency responses following an aircraft crash in February 2023), $2.8 million in proprietary software development costs, $2.3 million related to minority investment in certain companies, and the payment of assumed purchase price obligations of $1.0 million.
Financing Activities
For the nine months ended September 30, 2024, net cash provided by financing activities was $136.6 million. Cash provided by financing activities was driven by net proceeds from the issuance of common stock through a public offering of $121.8 million, net borrowing of $87.0 million, proceeds from the exercise of stock options of $2.0 million, partially offset by a partial redemption of the Series A-2 Preferred Stock of $60.0 million, dividends on the Series A-2 Preferred Stock of $8.3 million and repayments of finance leases of $4.4 million.
For the nine months ended September 30, 2023, net cash used in financing activities was $10.9 million. Cash used in financing activities was driven by the quarterly dividends on the Series A-2 Preferred Stock of $12.3 million, the 2021 Credit Facility term loan and the aircraft loan amortization payments of $9.1 million, the repayments of finance leases of $3.4 million, and the payment of acquisition-related contingent consideration of $1.5 million, partially offset by proceeds received from the aircraft loan of $10.9 million and the exercise of stock options of $4.5 million.
Credit Facilities
See Note 12 to our unaudited condensed consolidated financial statements included in Part I, Item 1. “Financial Statements.”
Series A-2 Preferred Stock
See Note 15 to our unaudited condensed consolidated financial statements included in Part I, Item 1. “Financial Statements.”
Critical Accounting Policies and Estimates
Our 2023 Form 10-K includes a summary of the critical accounting policies and estimates we believe are the most important to aid in understanding our financial results. There have been no material changes to those critical accounting policies and estimates as disclosed therein, other than as described in Note 2 to our unaudited condensed consolidated financial statements included in Part I, Item 1. “Financial Statements.”
Item 3. Quantitative and Qualitative Disclosures About Market Risk.
Interest Rate Risk
We have market risk exposure arising from changes in interest rates on our credit facility, which bears interest at rates that are benchmarked subject to the Company’s leverage ratio and SOFR. Based on our overall interest rate exposure to variable rate debt outstanding as of September 30, 2024, which factors in our interest rate swaps on $150.0 million of debt, a 1.0% increase or decrease in interest rates on the term loan, aircraft loan, and revolver would impact our annual income (loss) before income taxes by approximately $1.0 million.
Inflation Risk
We experienced higher labor and significantly higher travel and other direct costs in the fiscal year ended December 31, 2022 and December 31, 2023 as a result of inflation, particularly in our Measurement and Analysis and Remediation and Reuse segments. In the nine months ended September 30, 2024, we also experienced, and continue to experience, higher labor costs as a result of inflation. We believe we have successfully raised prices in businesses with short term contracts to offset these inflationary effects. We also have and are continuing to raise prices on medium term (one to four quarter) contracts as these contracts are renewed or new contracts are won, and as a result have been able to offset much of the impact of inflation to date. We expect to continue to raise prices if direct costs continue to increase, and although inflation has increased our Selling, general and administrative expense in the nine months ended September 30, 2024, we do not believe over a longer period of time that inflation will have a material effect on our business, financial condition or results of operations. If our costs were to become subject to additional and unanticipated significant sustained inflationary pressures, we may not be able to fully offset such higher costs through price increases. Our inability or failure to do so could adversely affect our business, financial condition and results of operations.
Foreign Exchange Risk
Foreign exchange risk exposure arises because we sell our services throughout the United States, Canada, Australia and Europe. Our exposure to this risk has increased significantly due to our acquisitions of Paragon and Matrix in Canada, EPIC in Australia, and to a lesser extent, Vandrensning in Europe. Revenues in certain foreign countries as well as certain expenses related to those revenues are transacted in currencies other than the U.S. dollar. As such, our future operating results are exposed to changes in exchange rates. When the U.S. dollar weakens against foreign currencies, the dollar value of revenues denominated in foreign currencies increases. When the U.S. dollar strengthens, the opposite situation occurs. Additionally, previously invoiced amounts can be positively or negatively affected by changes in exchange rates in the course of collection. A 1.0% increase or decrease in the U.S. dollar exchange rate would impact revenues by approximately $1.5 million and would have a negligible impact on annual net (loss) income.
Item 4. Controls and Procedures.
Evaluation of Disclosure Controls and Procedures
As required by Rule 13a-15(b) under the Exchange Act, our management, including our Chief Executive Officer and Chief Financial Officer, carried out an evaluation of the effectiveness of the design and operation of our disclosure controls and procedures (as defined in Rule 13a-15(e) under the Exchange Act), as of September 30, 2024, the end of the period covered by this Quarterly Report on Form 10-Q. Based on the foregoing, our Chief Executive Officer and Chief Financial Officer concluded that, as of September 30, 2024, the end of the period covered by this Quarterly Report on Form 10-Q, our disclosure controls and procedures were effective at the reasonable assurance level.
Internal Control Over Financial Reporting
There were no changes in our internal control over financial reporting (as defined in Rule 13a-15(f) under the Exchange Act) that occurred during the quarter ended September 30, 2024, that have materially affected, or are reasonably likely to materially affect, our internal control over financial reporting.
Limitations on Effectiveness of Controls
Our management, including our Chief Executive Officer and Chief Financial Officer, does not expect that our disclosure controls and procedures or our system of internal control over financial reporting will prevent or detect all errors and all fraud. A control system, no matter how well designed or operated, can provide only reasonable, but not absolute, assurance that the objectives of the system of internal control are met. The design of our control system reflects the fact that there are resource constraints, and that the benefits of such control system must be considered relative to their costs. Further, because of the inherent limitations in all control systems, no evaluation of controls can provide absolute assurance that all control failures and instances of fraud, if any, within the Company have been detected. These inherent limitations include the realities that judgments in decision-making can be faulty and that breakdowns can occur because of simple error or mistake. Additionally, controls can be circumvented by the intentional acts of individuals, by collusion of two or more people, or by management override of the controls. The design of any system of controls is also based in part on certain assumptions about the likelihood of future events, and there can be no assurance that the design of any particular control will always succeed in achieving its objective under all potential future conditions.
PART II—OTHER INFORMATION
Item 1. Legal Proceedings.
From time to time, we are subject to various legal proceedings that arise in the normal course of our business activities, including those involving labor and employment, anti-discrimination, commercial disputes and other matters. We are not a party to any litigation the outcome of which, if determined adversely to us, would individually or in the aggregate be reasonably expected to have a material adverse effect on our results of operations or financial position. Regardless of outcome, litigation can have an adverse impact on us because of defense and settlement costs, diversion of management resources and other factors.
Item 1A. Risk Factors.
There have been no material changes to our risk factors from the risk factors disclosed in our 2023 Form 10-K. The risks described in our 2023 Form 10-K, in addition to the other information set forth in this Quarterly Report on Form 10-Q, are not the only risks facing we face. Additional risks and uncertainties not currently known to us or that we currently deem to be immaterial also may materially adversely affect our business, financial condition and/or operating results.
Item 2. Unregistered Sales of Equity Securities and Use of Proceeds.
On July 1, 2024, we issued an aggregate of 30,953 shares of common stock to the former owner of Spirit as purchase price consideration. The issuance of common stock was exempt from the registration requirements of the Securities Act pursuant to Section 4(a)(2) thereof as a transaction by an issuer not involving any public offering.
Item 3. Defaults Upon Senior Securities.
None.
Item 4. Mine Safety Disclosures.
Not applicable.
Item 5. Other Information.
None.
Item 6. Exhibits.
* Filed herewith.
** Exhibit is furnished and shall not be deemed “filed” for purposes of Section 18 of the Exchange Act, or otherwise subject to the liabilities of that section, nor shall it be deemed incorporated by reference in any filing under the Securities Act, or the Exchange Act, except as shall be expressly set forth by specific reference in such filing.
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.
| | | |
|
| Montrose Environmental Group, Inc. |
|
|
|
|
Date: November 7, 2024 |
| By: | /s/ Allan Dicks |
|
|
| Allan Dicks |
|
|
| Chief Financial Officer |